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Abstract 
Biofabrication, or the 3D printing of biological-relevant tissues, is 
revolutionising our ability to treat patients who have suffered tissue loss as a result of 
trauma, disease or birth defect. As a subset of the Tissue Engineering field, 
biofabrication research is focussing on optimising the fabrication of implantable 
constructs, known as scaffolds, which provide a support structure for cell infiltration 
and growth, ultimately dissolving and restoring tissue, completely healing the patient. 
While research has focused on developing the mechanical capability to print structures 
using 3D printing, alongside biological advances to create highly biocompatible, 
bioactive constructs which have enhanced regenerative properties, less research has 
focused on developing methods of designing scaffolds which are anatomically 
matched to individual patients. 
In this thesis, a novel method for designing patient-specific scaffold for bone 
regeneration, to be fabricating using the melt-electrospinning 3D printing technique, 
was developed. The method was then applied to three clinically-relevant case studies, 
examining how to accurately design scaffolds to treat a wide range of orthopaedic 
injuries. Medical scan data was obtained from two patients and a third defect was 
recreated from an anatomical skull model. Following data acquisition, scaffolds were 
designed using 3D modelling software and processed into slices. These slices were 
processed by a proprietary g-code generation program which automatically generates 
the required computer instructions to fabricate each of the suitable layers using a melt-
electrospinning machine. A skull scaffold to treat a large cranial defect, a femur 
scaffold to fill a void after a realignment procedure and a patella scaffold to improve 
the external shape of the reconstructed bone were successfully designed. The computer 
instructions were then trialled on the melt-electrospinning machine to assess the 
success of the generated g-code. 
In collaboration with the Biofabrication and Tissue Morphology group at the 
Queensland University of Technology, as well as the Orthopaedic Unit at the Royal 
Brisbane Hospital, this research project has successfully demonstrated the ability to 
fabricate patient-specific scaffolds, which one day could be used clinically to treat 
patients suffering from bone loss.  
 Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration iii
Table of Contents 
Keywords .................................................................................................................................. i 
Abstract .................................................................................................................................... ii 
Table of Contents .................................................................................................................... iii 
List of Figures ...........................................................................................................................v 
List of Tables ......................................................................................................................... vii 
List of Abbreviations ............................................................................................................ viii 
Research Dissemination .......................................................................................................... ix 
Statement of Original Authorship .............................................................................................x 
Acknowledgements ................................................................................................................. xi 
Chapter 1: Introduction ...................................................................................... 1 
1.1 Background .....................................................................................................................1 
1.2 Purposes ..........................................................................................................................4 
1.3 Significance and Scope ...................................................................................................5 
1.4 Thesis Outline .................................................................................................................6 
Chapter 2: Literature Review ............................................................................. 7 
2.1 Tissue Engineering and Bone Regeneration ...................................................................7 
2.1.1 Biomaterials ........................................................................................................10 
2.1.2 Scaffold Porosity and Vascularisation ................................................................15 
2.1.3 Biodegradation ...................................................................................................17 
2.1.4 Scaffold fibre geometry ......................................................................................18 
2.1.5 Scaffold Viability Assessment ...........................................................................19 
2.1.6 Implant Requirements ........................................................................................20 
2.2 Biofabrication ...............................................................................................................21 
2.2.1 Additive Manufacturing Techniques ..................................................................21 
2.2.2 Melt-Electrospinning ..........................................................................................26 
2.2.3 Machine Control Language ................................................................................28 
2.3 3D Printing and Modelling in Orthopaedics .................................................................35 
2.3.1 Models for Surgical Planning .............................................................................35 
2.3.2 Surgical Guides, Tools, Templates .....................................................................36 
2.3.3 Patient-Specific Scaffolds for Bone Regeneration .............................................36 
2.4 Summary and Implications ...........................................................................................40 
Chapter 3: Research Design .............................................................................. 43 
3.1 Method and Procedures ................................................................................................43 
3.1.1 Method................................................................................................................43 
3.1.2 Procedure for Case 1 ..........................................................................................46 
3.1.3 Procedure for Case 2 ..........................................................................................49 
3.1.4 Procedure for Case 3 ..........................................................................................51 
3.1.5 Scaffold Microscopy Imaging ............................................................................53 
3.1.6 Scaffold Measurements ......................................................................................53 
3.2 Participants ...................................................................................................................54 
 iv Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration 
3.3 Instruments ................................................................................................................... 54 
3.4 Analysis ........................................................................................................................ 54 
3.5 Ethics and Limitations ................................................................................................. 55 
Chapter 4: Results .............................................................................................. 57 
4.1 Case 1: Skull ................................................................................................................ 58 
4.2 Case 2: Femur .............................................................................................................. 59 
4.3 Case 3: Patella .............................................................................................................. 60 
4.4 Measurements .............................................................................................................. 61 
Chapter 5: Discussion ........................................................................................ 63 
5.1 Biological Considerations ............................................................................................ 64 
5.1.1 Biomaterials and Biological Ingredients ............................................................ 64 
5.1.2 Biocompatibility ................................................................................................ 64 
5.2 Physical Design Considerations ................................................................................... 64 
5.2.1 Fibre Diameter ................................................................................................... 64 
5.2.2 Patient-Specific Design ...................................................................................... 65 
5.2.3 Density/Porosity................................................................................................. 67 
5.2.4 Laydown Pattern ................................................................................................ 68 
5.3 Future Work ................................................................................................................. 70 
5.3.1 Layer Alignment ................................................................................................ 70 
5.3.2 Tailored Tissue Growth ..................................................................................... 71 
5.3.3 Stability .............................................................................................................. 71 
5.3.4 Automaticity ...................................................................................................... 71 
5.4 Limitations and Challenges .......................................................................................... 73 
5.4.1 Versatility .......................................................................................................... 73 
5.4.2 Speed .................................................................................................................. 73 
5.4.3 Sterility .............................................................................................................. 74 
5.4.4 Accuracy ............................................................................................................ 74 
5.4.5 Ethical and Social Challenges ............................................................................ 74 
Chapter 6: Conclusions...................................................................................... 77 
Bibliography ............................................................................................................. 79 
Appendices ................................................................................................................ 97 
 Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration v
List of Figures 
Figure 1 Workflow of scaffold design process from data acquisition to scaffold 
design and fabrication. ................................................................................... 3 
Figure 2 Significant growth in the field of bone tissue engineering as 
demonstrated by the number of Scopus results for ‘bone tissue 
engineering’ publications, plotted against time. ............................................ 9 
Figure 3 Examples of cell growth on various cross-hatch structured tissue 
engineering constructs. (a) Fine fibres and very small pores often lead 
to hypoxia and insufficient nutrient/oxygen supply and waste removal; 
(b) fine fibres but larger pore sizes facilitate adequate cell attachment 
without risk of starvation; and (c) large pores with large fibres inhibit 
cell interactions and hinder tissue development. Scale bar = 100µm .......... 16 
Figure 4 Key requirements for successful bone tissue engineering constructs, as 
summarised from the literature review. ....................................................... 20 
Figure 5 Schematic diagrams of additive manufacturing techniques commonly 
used in biofabrication. Reproduced with permission from Mota, 
Puppi, Chiellini, & Chiellini, 2015. Copyright © 2012 John Wiley & 
Sons, Ltd. ..................................................................................................... 22 
Figure 6 Schematic diagram of melt-electrospinning machine, demonstrating 
the use of the water heater to melt the material, syringe pump for 
controlled extrusion onto the moving collector plate and high voltage 
power supplies delivering the large electric field for micro-scale fibre 
extrusion. ...................................................................................................... 26 
Figure 7 Melt-electrospinning machines must maintain constant extrusion due 
to the interaction of the polymer with the high electric field. ...................... 29 
Figure 8 Schematic diagram of the way (a) an FDM g-code regenerator might 
‘view’ the required solution to filling in a complex shape such as a 
doughnut (grey) versus (b) the printing pattern required by a melt-
electrospinning machine. The FDM printer can print a series of 
continuous and discontinuous stripes across the shape, stopping the 
flow of material across the hole and continuing on the other side. 
However, the melt-electrospinning machine cannot stop and start and 
therefore must print the left side, top and right side, before doubling 
back to fill in the missing bottom section. ................................................... 30 
Figure 9 Use of interpolation to approximate the z- scaffold geometry. (a) 
demonstrates the case where the information in the lower slice is 
extrapolated over the 2mm until the new slices changes the design. 
This is known as ‘piecewise constant interpolation’. (b) shows the use 
of the linear interpolation, connecting corresponding regions of the 
lower and upper slice with a straight line. (c) shows the use of a spline 
interpolation to smoothly approximate the content between successive 
CT slices. This is calculated using a series of polynomial functions........... 31 
 vi Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration 
Figure 10 Melt-electrospinning has been used to fabricate a variety of scaffold 
architectures including (a) (d) non-woven mats (Reproduced from 
Nivison-Smith & Weiss, 2011), (b) (e) ordered cross-hatch scaffolds 
(Brown et al., 2011) and (c) (f) tubular meshes (Reproduced from 
Brown et al., 2012, Copyright © 2012 John Wiley & Sons, Ltd.). .............. 32 
Figure 11 This research project intends to bridge the gap between the 
successful pre-clinical studies showing the efficacy of melt-
electrospun PCL scaffolds for bone regeneration and the clinical 
expectation that scaffolds must be patient-specific in design. Graphic 
from YCIS Blog, 2014. ................................................................................ 41 
Figure 12 Dual-density scaffold layer configurations. ............................................... 51 
Figure 13 Design process for the skull defect: (a) the skull, (b) the 3D model, 
(c) the scaffold design, (d) slice image, (e) generated g-code, (f) 
fabricated scaffold. (g) shows the SD scaffold with micrographs (h)-(i) 
showing the fibre structure at x20 magnification. Similarly, an 
overview of the DD scaffold is shown in (j) with micrographs 
depicting the different layers at x20 magnification. .................................... 58 
Figure 14 Design process for the femur defect: (a) corrected 3D model, (b) use 
of sketch planes to define the outer boundaries of the scaffolds, (c) loft 
tool used to complete the scaffold, (d) scaffold design, (e) generated 
g-code and (f) fabricated scaffold. Next, overviews of the 10-layer 
scaffolds for SD (g), DD-A (h) and DD-B (i) are shown with 
micrographs at x20 magnification (j)-(l) demonstrating the fibre order 
for the three scaffolds respectively. ............................................................. 59 
Figure 15 Design process for the patella defect: (a) the original, uncorrected 
model, (b) the proposed treatment plan, (c) the contralateral patella 
overlaid with the defective patella, (d) the subtracted region yielding 
the scaffold design, (e) generated g-code and (f) fabricated scaffold. 
Next, overviews of the 10-layer scaffolds for SD (g), DD-A (h) and 
DD-B (i) are shown with micrographs at x20 magnification (j)-(l) 
demonstrating the fibre order for the three scaffolds respectively. .............. 60 
 
 Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration vii
List of Tables 
Table 1 Studies demonstrating successful pre-clinical trials using 3D printed 
scaffolds for the regeneration of critical size long bone defects. The 
animal, bone, size of defect, scaffold material and use of cells and 
growth factors (GFs) are noted. ................................................................... 38 
Table 2 Animal studies for the development of osteochondral defect 
regenerative solutions. ................................................................................. 39 
Table 3 Fabricated scaffold names and descriptions for the single-density (SD) 
and dual-density (DD) scaffold designs. The appendix location of the 
g-code for each scaffold has also been indicated. ........................................ 57 
Table 4 Measurements at various locations for each of the defects to validate 
the accuracy of printed construct size. Each measurement was 
recorded on the defect model, scaffold model and printed scaffold for 
comparison and the percentage accuracy of the printed measurement 
compared to the model was calculated. ....................................................... 61 
Table 5 Average diameter of the fibres comprising the SD Skull, Femur and 
Patella scaffolds. .......................................................................................... 61 
Table 6 Automated biofabrication machine selection parameters. ............................ 73 
 
 viii Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration 
List of Abbreviations 
2D  two-dimensional  
3D  three-dimensional  
BMP  Bone Morphogenetic Protein 
CT  Computed Tomography  
DBM  Demineralised Bone Matrix 
DD  dual-density 
ECM  Extracellular Matrix 
FDA  Food and Drug Administration 
FDM  Fused Deposition Modelling  
MSC  Mesenchymal Stem Cell 
PCL  Polycaprolactone 
PLA  Polylactic Acid 
PGA  Polyglycolic Acid  
RBH  Royal Brisbane Hospital  
SD  single-density 
SLA  Stereolithography 
SLS  Selective Laser Sintering  
SFM  Structure from Motion 
TE  Tissue Engineering 
 
 
  
 Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration ix
Research Dissemination 
Conference Presentations 
Paxton NC, Powell SK, Crooks N, Tetsworth KD, Woodruff MA (2015) Poster 
Presentation: The Future of Biofabrication: Designing Patient-Specific Melt-
Electrospun Scaffolds for Bone Regeneration. IHBI Inspires Postgraduate Student 
Conference, 19-20 Nov 2015, Brisbane, Australia. 
Woodruff MA, Powell SK, Paxton NC (2016) Oral Presentation: Biofabrication in 
Orthopaedics: The Future of Regenerative Medicine. Orthopaedic Research Society 
Annual Meeting, 5-8 March 2016, Orlando FL, USA. 
 
Outreach Activities 
Powell SK, Ristovski N, McLaughlin M, Paxton NC, Woodruff MA (2015) 3D 
Printing Body Parts: The Future of Regenerative Medicine Workshop for the Vice-
Chancellor’s STEM Camp 2015. STEM High School Engagement, 28 Sep-2 Oct 2015, 
Brisbane, Australia. 
 
Publications 
Paxton NC, Powell SK, Tetsworth K, Woodruff MA. (2016) Biofabrication: The 
future of regenerative medicine. Techniques in Orthopaedics, 31(3): 180-203. 
  
 x Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration 
Statement of Original Authorship 
The work contained in this joint masters program undertaken between QUT and 
the University of Würzburg has not been previously submitted to meet requirements 
for an award at these or any other higher education institution. To the best of my 
knowledge and belief, the thesis contains no material previously published or written 
by another person except where due reference is made. 
 
 
 
Signature: 
 
Date:   19/05/17   
 
 
  
QUT Verified Signature
 Designing Patient-Specific 
Melt-Electrospun Scaffolds for Bone Regeneration xi
Acknowledgements 
I thank my principal supervisor, A/Prof Mia Woodruff, for all the support and 
encouragement she gave me throughout the Biofabrication Masters program. I am 
grateful for the many incredible opportunities she has given me to grow academically, 
professionally and personally. I would also like to extend my gratitude to Dr Sean 
Powell for his assistance in developing this project and keeping me on track as well as 
to my external associate supervisor, Dr Kevin Tetsworth, for providing such a valuable 
clinical insight for this project. 
This project would not have been possible without the help of Nathan Crooks 
who wrote the g-code generation program used in this project. I would also like to 
acknowledge Nicholas Green for providing me with a link to the Orthopaedics Unit at 
the RBH and providing me with all the data I needed. His continued support and input 
into this project was invaluable. 
I would like to thank all the members of the Biofabrication and Tissue 
Morphology Group at QUT for making me feel so welcome at IHBI for this short 
project and for their advice, help, inspiration and friendship. In particular, I would like 
to thank David Forrestal for his assistance in learning 3D modelling software as well 
as Sam Liao, Nikola Ristovski and Edward Ren for teaching me to use the melt-
electrospinning machines. I would like to acknowledge the incredible administrative 
support from Joanne Richardson without whom the research group would barely 
function! I am also grateful to many other IHBI members for their friendship and 
support, particularly in the Postgraduate Student Committee and Orthopaedics, 
Trauma and Emergency Care Program. 
I am grateful to the four other QUT Biofabrication Masters students who have 
been a constant source of inspiration. I wish Madeline Hintz, Sammy Florczak, 
Rebecca McMaster and Erin McColl all the best in the biofabrication endeavours! 
Finally, I would not have made it through this very busy and challenging year 
without the support of my family and friends. I am deeply grateful to my sister, Viva 
Paxton, as well as Julian Skinner for their help editing this thesis. I am also eternally 
grateful to my parents for their love and support.  
 Chapter 1: Introduction 1 
Chapter 1: Introduction 
1.1 BACKGROUND 
Each year, approximately 6.5 million people suffer from bone fractures in the 
USA (Yunus Basha, T.S., & Doble, 2015). Treating major bone defects, either as a 
result of trauma, spinal fusion, tumour excision, or treatment of malunion or non-union 
remains a significant clinical challenge and major burden on global healthcare. 
The current gold standard treatment for large bone defects is grafting. Each year, 
there are 500,000 grafting procedures performed in the United States and 2.2 million 
procedures worldwide (Yunus Basha et al., 2015). Grafting involves harvesting 
replacement tissue from the patient (autografting) or donor (allografting) and 
surgically implanting it into the defect site to assist the healing process (Herford & 
Dean, 2011). Autografts have three primary benefits: they assist new bone and 
vasculature growth, deliver key growth factors and other biological stimuli to signal 
new bone growth and provide mature, live bone for structural support (Avery, Samad, 
Athanassious, & Cohen, 2011). However, there is an increasing demand for bone 
donors, particularly due to the aging population, and a limited supply of donor tissue. 
Further, surgical complication rates are high and patients can suffer from severe pain, 
hematoma, infections, nerve damage, hernias and fractures at the donor site, in addition 
to the original defect (Avery et al., 2011). Tissue engineering seeks to create an 
alternative treatment to minimise these complications and provide improved patient 
outcomes.   
If substances which are able to replace damaged tissue while maintaining the 
required structural and physiological support could be fabricated, grafting material 
may not be required. Available materials range in biocompatibility and mechanical 
properties and offer a range of more readily-available materials suitable for treating 
bone loss. The use of resorbable, biodegradable materials have also opened the 
window on a new treatment area known as ‘regenerative medicine’, where the grafting 
substitutes not only replace the missing tissue but instigate bone regeneration whilst 
slowly dissolving into the body. This facilitates partial or complete restoration of the 
tissue with no permanent implants. 
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Tissue engineered constructs can be fabricated using a number of physical and 
chemical processes. Most recently, the use of additive manufacturing, more commonly 
known as 3D printing, has revolutionised the ability to fabricate customised devices. 
Using a layer-by-layer approach, 3D printers build objects by depositing layers of a 
material in computer-controlled 2D patterns which stack on top of each other to form 
a 3D object. Since this is an additive process, adding material to the object to build it 
up, rather than traditional subtractive processes, there is significantly less material 
wastage. Also, there is significantly more control of the internal architecture of the 
objects as the interior of the object is exposed during each layer of fabrication.  
The use of additive manufacturing has revolutionised tissue engineering and has 
enabled a new and expanding field known as biofabrication to be born. Simply put, 
biofabrication is the additive manufacturing, or 3D printing, of biologically relevant 
tissue substitutes. The field of biofabrication has seen a massive increase in 
international research and is scheduled for continued growth following successful pre-
clinical trials and imminent clinical translation. The 3D printed constructs, often 
known as ‘scaffolds’ can be used as a substitute for grafting material, in combination 
with cells and other biological materials, to instigate tissue regeneration. By using 
biodegradable materials, these constructs slowly dissolve and, in time, completely 
restore the tissue.   
The ability to customise each individual tissue engineered construct is one of the 
primary benefits of additive manufacturing over other fabrication methods. Therefore, 
research is focussing on optimising the process of designing anatomically relevant 
scaffolds for clinical applications. This process is depicted schematically in Figure 1. 
Following an injury, a patient can undergo medical, photometry or laser scans to 
identify the defect area. These scan data sets can be interpreted into a 3D model which 
is then used to design the exterior and interior architecture of the implant, including 
the design of blood vessels and tailored scaffold density to match the native tissue. The 
scaffold design is then sliced into a series of 2D layers and computer instructions to 
guide the printing of each layer by the 3D printer are created. Finally, the scaffold can 
be fabricated with a 3D printing machine and biological stimuli such as cells and 
growth factors which assist tissue regeneration are added. The completed scaffold is 
then surgically implanted back into the patient, facilitating tissue regeneration as the 
scaffolds dissolves and ultimately heals the defect. 
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Figure 1 Workflow of scaffold design process from data acquisition to scaffold design and fabrication.  
 
The Biofabrication and Tissue Morphology group at the Queensland University 
of Technology (QUT) is devising a tissue engineering solution by combining 3D 
printed polymer scaffolds with cells and growth factors to produce customisable 
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replacement tissue constructs for bone regeneration. The vision is that one day, patients 
who have experienced bone loss due to injury or disease can have bed-side custom 
tissue replacement constructs produced and implanted without the current risks 
associated with grafting. 
In 2014, QUT launched a world-first international double masters degree in 
biofabrication, offering five students the opportunity to undertake a years’ study at 
QUT in 2015 before travelling to Europe to complete another year of study in 2016. 
This research project is submitted in fulfilment of the requirements for the degree of 
Master of Applied Science (Research) at QUT, after one year of study including the 
completion of five coursework units. 
This chapter outlines the background (section 1.1) and purpose of this research 
(section 1.2). Section 1.3 describes the significance and scope of this research and 
section 1.4 includes an outline of the remaining chapters of the thesis. 
1.2 PURPOSES 
The aim of this research project is to develop a novel technique for 
translating medical images into computer instructions. These instructions are 
used to control the 3D printing of patient-specific tissue engineering constructs 
with the required morphological and microstructural features for optimal tissue 
regeneration. This research will provide a vital link between the significant 
engineering, biological and histological developments of biofabricated bone constructs 
and drive this technology toward becoming a routine clinical substitute to grafting. 
Specifically, this thesis will develop a method to translate the patient CT scan 
data into a 3D model of the defect site. This will be used to guide the design of the 
exterior of the scaffold in CAD programs. Finally, the scaffold design will be 
translated into the appropriate computer instructions to guide the 3D printer. This 
method will then be validated using patient data gathered from the RBH’s Orthopaedic 
Unit, under the guidance of Dr Kevin Tetsworth. Scaffolds will be designed for each 
patient using the proposed method and the success of the design procedure will be 
assessed for its efficacy in future clinical studies. 
Two sub-aims have been identified: 
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1. To design patient-specific scaffolds using a single, constant filling pattern. 
The scaffold will be printed using fibres of uniform spacing throughout the 
structure.  
2. To redesign scaffolds with multiple zones corresponding to regions of more 
and less dense bone. These regions will be identified using CT patient data 
and translated into computer instructions such that the printer will fill the 
dense bone regions with thinly spaced fibres and will use sparser filling for 
the less dense bone regions. 
1.3 SIGNIFICANCE AND SCOPE 
This research project is crucial to progressing 3D printing scaffold fabrication 
into the clinical realm. Patient-specific architecture is a mandatory requirement for a 
successful biofabrication system and as such, the ability to design scaffolds to suit any 
defect site must be developed and optimised. Until now, pre-clinical research has 
focussed on pre-defined, uniform, reproducible defect sites, such as a widely used 
cylindrical tibial defect or circular cranial defect. Understandably, these models are 
crucial to developing the required breadth of pre-clinical research before moving the 
technology into routine clinical use. However, with clinical translation imminent, this 
research project propels the significant advances in the research area into the clinically-
feasible domain. 
To date, there have been no published studies describing the fabrication of 
patient-specific melt-electrospun scaffolds based on clinical data. Furthermore, dual-
density melt-electrospun scaffolds have also not yet been investigated, although the 
requirement has been widely realised. This thesis therefore aims to fill both these 
research gaps in the two sub-aims listed above. 
With bone tissue regeneration as the focus of this investigation, the project will 
be undertaken in collaboration with Dr Kevin Tetsworth from the RBH Orthopaedic 
Unit and Master of Engineering student, Nicholas Green, who is completing his project 
titled “Impact of In-House 3D Rapid Prototype Technology used as a Preoperative 
Planning Aid for Complex Fracture Treatment” (2015-2016, QUT). Also, proprietary 
g-code generation program which was developed as part of a Vacation Research 
Experience Scheme (VRES) by Mechatronics Engineering student, Nathan Crooks. 
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The research team was also involved in preparing and presenting a 4-day 
intensive workshop for sixteen Year 11 students from high schools across Queensland 
who attended the QUT Vice-Chancellor’s STEM (Science, Technology, Engineering, 
Maths) Camp 2015, held at QUT Gardens Point. The workshop, titled “3D Printing 
Body Parts: The Future of Regenerative Medicine” aimed to introduce the students in 
the field of biofabrication, medical engineering and medical physics. The students 
were instructed to use a cheap and accessible imaging method to design a scaffold 
suited to a number of bone models with artificial defects. The scaffolds were then 3D 
printed on a Fused Deposition Modelling (FDM) printer and the students reported on 
their project to the other camp attendees. Additional to the primary aims of this 
research project, the method developed for the workshop will be presented as a 
demonstration of the use of alternative imaging techniques for the design of melt-
electrospun patient-specific implants. 
This is a design-based project, with the primary aim of developing and validating 
a novel method of designing scaffolds for fabrication. Case studies were selected by 
an orthopaedic surgeon for their relevance to the research as a means of validating the 
model using clinically relevant data. 
1.4 THESIS OUTLINE 
Chapter 2 provides a comprehensive review of the literature surrounding tissue 
engineering, bone regeneration and the use of biofabrication in orthopaedic treatments. 
Chapter 3 describes the methods used to design the scaffolds while Chapter 4 details 
the results of the applied method in three case studies. Chapter 5 provides a discussion 
of the results along with recommendations for future research. Conclusions are 
summarised in Chapter 6. 
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Chapter 2: Literature Review 
This chapter begins with an overview of tissue engineering and bone 
regeneration, highlighting how tissue engineering research employs biomimicry of the 
natural bone healing process to develop tissue substitutes (section 2.1). The use of 
various biomaterials will then be discussed (section 2.1.1), along with the importance 
of porosity and vascularisation (section 2.1.2), biodegradation (section 2.1.3) and fibre 
geometry (section 2.1.4). These requirements for successful tissue substitutes are then 
summarised in section 2.1.6. 
The field of biofabrication is introduced in section 2.2, including a description 
of commonly used additive manufacturing techniques as fabrication methods (section 
2.2.1). Melt-electrospinning is highlighted as a promising technique and is discussed 
in terms of its operating principles and success in in vitro and in vivo studies (section 
2.2.2) as well as the required operating instructions and input (section 2.2.3). 
The use of additive manufacturing in orthopaedic treatments is outlined in 
section 2.3, including the fabrication of models for surgical planning (section 2.3.1), 
surgical guides, tools and templates (section 2.3.2) and finally, how patient-specific 
implants can be used in orthopaedic treatments (section 2.3.3). 
Finally, the implications of the literature and knowledge gap are identified in 
section 2.4. 
2.1 TISSUE ENGINEERING AND BONE REGENERATION  
Bone is the organ of the human anatomy responsible for mechanical and 
structural integrity for movement and organ protection, as well as providing a pathway 
for the maintenance of mineral homeostasis. Bone is composed of a rigid matrix 
comprising collagen, resulting in high tensile strength, as well as hydroxyapatite 
(Ca10(PO4)6(OH)2) for compressional strength and other calcium and phosphate salts 
(Morgan, E; Barnes, G; Einhorn, 2009). This matrix, known as the Extracellular 
Matrix (ECM) provides the structure for bone cells, namely osteoblasts for cell 
formation, mature bone osteocytes, and osteoclasts which breakdown bone for 
subsequent regeneration. While the external architecture of the 206 bones in the human 
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body varies widely, bones are commonly comprised of a hard, outer layer of dense 
bone known as cortical bone. This provides strong mechanical support. Within, 
trabecular bone is an open, porous network of ‘spongy’ bone, allowing spaces for the 
bone marrow and stem cells (Clarke, 2008). 
Bone naturally possesses the capacity for regeneration and repair in response to 
injury, the process of which is well understood. First, initial bleeding from the 
damaged bone coagulates to form a clot, providing a vital healing microenvironment. 
The clot is then invaded by a fibrin network scaffold known as a fracture hematoma. 
This assists cell migration and adhesion alongside platelets, which release growth 
factors crucial to the healing process. This is known as the inflammation stage where 
chemotaxis signalling mechanisms attract the cells necessary to induce healing 
(Broughton, Janis, & Attinger, 2006; Witte & Barbul, 1997). The formation of a callus 
overlying the defect site begins to form cartilage. Subsequently, biochemical processes 
allow for the systematic calcification of the tissue, leading to the formation of blood 
vessel ingrowth. These deliver the required perivascular cells that instigate the 
formation of woven bone and resorption of the calcified cartilage. Finally, systematic 
remodelling of the bone leads to complete bone healing (Einhorn, 1998). 
For small fractures, this natural healing process may be complete within just a 
few weeks. However, in some cases, medical intervention is required (Perry, 1999). 
For critical-sized bone loss, where the size of the defect is beyond the scope of the 
body’s natural healing ability, implants may be used to stabilise the defect site, replace 
lost tissue and/or stimulate healing. An autograft or allograft may be used to instigate 
bone regeneration and restore the tissue (Finkemeier, 2002). However, donor material 
is largely inaccessible, surgical complication rates are high and there are a number of 
additional costs associated with many of the existing treatments, including return 
hospital visits (Herford & Dean, 2011).  
Tissue engineering is a rapidly growing research area that seeks to meet this 
persistent clinical and resource need by developing solutions to restore tissue or organs 
that are lost or damaged through disease, trauma or congenital defects. By 
incorporating the body’s own regenerative capacity and fabricated biomaterial 
structures, researchers aim to ease the demand for donor tissue and improve clinical 
outcomes through the production of tissue engineering constructs (Langer & Vacanti, 
1993). Within the context of bone treatments, tissue engineering solutions can be 
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divided into two distinct groups: those that stimulate bone regeneration and those that 
provide a permanent solution. 
Bone tissue engineering is a rapidly growing field and researchers are developing 
techniques based largely on the concept of biomimicry. Since the composition and 
regenerative capacity of bone is so well-understood, tissue engineering substitutes are 
mounting in complexity to mimic the physiological processes involved. Therefore, 
synthetic bone graft substitutes are commonly constructed using an artificial 
extracellular matrix (ECM) scaffold, cells and growth factors (Motamedian, 
Hosseinpour, Ahsaie, & Khojasteh, 2015). A scaffold, often fabricated from similar 
biomaterials to natural bone, allows for rapid cell infiltration and proliferation, offering 
enhanced regenerative capacity for critical-sized defects. In addition, autologous cells, 
those extracted from the individual patient, and growth factors can be added to 
stimulate bone regeneration (Hutmacher, 2000; Hutmacher, Schantz, Lam, Tan, & 
Lim, 2007). 
 
Figure 2 Significant growth in the field of bone tissue engineering as demonstrated by the number of 
Scopus results for ‘bone tissue engineering’ publications, plotted against time.   
 
This continued need for resorbable bone graft substitutes has given rise to the 
explosive new $850 million market for bone graft substitute materials, led by 
biomedical companies such as Medtronic, Stryker, DePuy Synthes, Wright Medical, 
Zimmer and many others (Dyrda, 2015). Artificial bone grafts often consist of 
demineralized bone matrix, calcium phosphate-based materials, hydroxyapatite, 
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collagen or synthetic polymers. These materials are often sold as injectable putties or 
pastes, where the material is injected directly into the defect site and undergoes a 
solidification process to form a porous void filler. Alternatively, granules and other 
grains of the materials can be mixed into a paste in the operating theatre or already-
hard ‘strips’, ‘blocks’ or ‘sponges’ can be formed into the appropriate shape for 
implantation. Most solutions rely on biocompatible, resorbable materials which 
facilitate bone regeneration whilst simultaneously degrading.  
Additionally, there is a growing body of literature that recognises the importance 
of more sophisticated and robust bone regeneration techniques using advance 
manufacturing methods, composite or ‘smart’ materials and more complex biological 
and technological innovations (Murphy & Atala, 2014); the materials, structural and 
biological properties of which will now be discussed. 
2.1.1 Biomaterials 
 Metallic implants: Commonly, titanium, titanium alloys or stainless steel are 
used for non-regenerative implants. Metals generally have excellent mechanical 
properties, including high strength and wear resistance, making them 
particularly suitable for high load-bearing regions. Metallic implants have seen 
recent worldwide success in a number of treatments including total 
calcanectomy and sternocostal reconstructions for chondrosarcoma using 3D 
printed titanium replacements (Aranda, Jiménez, Rodríguez, & Varela, 2015; 
Imanishi & Choong, 2015). 
While these treatments have been largely successful, there are still a number of 
recognised drawbacks with metal implants, from complications at airport 
security to significant risks of toxicity due to the release of metal ions into the 
bloodstream after wear (Hallab, Merritt, & Jacobs, 2001). Also, the lack of tissue 
adherence has led to the development of biocompatible surface coating for more 
effective integration into the defect site (Rieger et al., 2015; Wong, Eulenberger, 
Schenk, & Hunziker, 1995).   
 Calcium-based materials: It is widely understood that bone is made 
predominantly from a mineralised organic matrix made from hydroxyapatite and 
other calcium and phosphate products. Therefore, biomimicry of the natural 
bone components has motivated the development of calcium-based biomaterials 
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which are inherently osteoconductive and resorbable. Calcium-based injectable 
putties and bone cements have been used clinically since the 1980s, including 
hydroxyapatite (HA), β-Tricalcium phosphate (β-TCP) and calcium sulphate 
among many others (Calori, Mazza, Colombo, & Ripamonti, 2011). The FDA 
has readily approved many products for use in orthopaedics, primarily due to the 
products’ low risk approach. The American Association of Tissue Banks 
summarised that approximately 40% of clinically available bone graft products 
are calcium-based (American Association of Tissue Banks, 2010). 
After implantation, these products act as a substitute ECM, offering a familiar 
porous network for cell infiltration, migration and proliferation, eventually 
restoring the tissue. However when set, calcium-based biomaterials have a high 
degree of brittleness, low fracture strength and unpredictable degradation rates. 
To alleviate this, composites have been the subject of extensive investigation. 
In 2012, Styker claimed that its Vitoss Bone Graft Substitute was the “#1 selling 
synthetic bone graft with over 425,000 implantations worldwide” (Stryker, 
2015). The product contains β-TCP in combination with Bioglass (see Bioglass 
section) and resorbs during the natural remodelling process. Recent studies have 
documented successful bone regeneration with silicate-substituted calcium 
phosphate with enhances strut porosity (Hutchens, Campion, Assad, Chagnon, 
& Hing, 2016), calcium phosphate-bisphosphonate composites (Schlickewei et 
al., 2015), magnesium-doped β-TCP with amorphous calcium phosphate (Singh, 
Roy, Lee, Banerjee, & Kumta, 2014) as well as calcium phosphate strengthened 
with poly-lactic acid (W.-C. Chen, Ko, Yang, Wu, & Lin, 2015). 
 Bioglasses and glass-ceramics: Other ceramic materials include Bioglass and 
glass-ceramics, which offer similar properties to the calcium-based biomaterials 
mentioned above. In addition, however, amorphous bioglass (referred to as 
bioactive glass) has been shown to have excellent osteoinductive properties as 
well as highly controlled degradation rates (Gorustovich, Roether, & Boccaccini, 
2010; Rahaman et al., 2011). Also, during degradation, they convert into a 
biologically active form of hydroxyapatite that assists with tissue binding 
(García-Gareta, Coathup, & Blunn, 2015; Gorustovich et al., 2010). 
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Bioglass has been used extensively to repair bone defects in orthopaedic 
treatments including as a primary ingredient in NovaBone (NovaBone Products 
LLC). The particulate is mixed with blood from the patient into a putty before 
being packed into the defect site. This performed well compared to autografts in 
a clinical study (Ilharreborde et al., 2008; Jones, 2013). Furthermore, the 
development of bioglass materials with strontium substitution (Basu, 
Sabareeswaran, & Shenoy, 2015; Gentleman et al., 2010; Jebahi et al., 2012; 
O’Donnell, Candarlioglu, Miller, Gentleman, & Stevens, 2010; Santocildes-
Romero et al., 2015) as well as polymer composites (Poh et al., 2016; Ren et al., 
2014) has seen significant in vitro and in vivo success.  
 Demineralised Bone Matrix (DBM): DBM bone graft substitutes offer a range 
of benefits over other biomaterials. Allograft material is treated using acid 
extraction to demineralise the tissue, yielding a combination of collagen, non-
collagenous proteins and growth factors (García-Gareta et al., 2015). Naturally 
occurring in bone, these biomaterials provide a successful microenvironment for 
osteogenesis. While many DBM-based products have already seen wide clinical 
success, including products from Osteotech, Exactech and Integra 
Orthobiologics (American Association of Tissue Banks, 2010), more advanced 
regenerative techniques are still widely researched. Successful in vitro and in 
vivo results were reported for the use of cell-derived pro-osteogenic ECM in 
combination with clinical grade DBM with (Ravindran, Huang, Gajendrareddy, 
& Narayanan, 2015). Furthermore, there has been increasing interest in 
incorporating DBM with polymer scaffolds (Han, Song, Kang, Lee, & Khang, 
2015; Y. M. Lee et al., 2012; Meseguer-Olmo et al., 2013). 
 Collagen: As discussed in section 2.1, collagen is one of the primary 
components of natural bone ECM. As such, it is widely acknowledged to be a 
viable and highly successful biomaterial due to its versatility in composites and 
high biocompatibility. Similar to the calcium- and DBM-based materials, 
collagen suffers from poor mechanical properties which has limited its 
translation into orthopaedic treatments and therefore, composites with other 
more mechanically robust materials have been developed (Cunniffe & O’Brien, 
2011). Promising results have been published for collagen-bioglass composite 
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scaffolds (Sarker, Hum, Nazhat, & Boccaccini, 2015) as well as hydroxyapatite 
and TCP (Yeo & Kim, 2012).  
Clinically, bovine sponges have been used in Medtronic’s INFUSE bone graft 
as well as Stryker’s OP-1 along with growth factors to stimulate bone 
regeneration (see Biological Stimuli section). In both cases, however, the 
collagen sponge is used as simply a carrier for the growth factor and is quickly 
resorbed into the body, rather than providing a scaffold for cellular growth 
(Cunniffe & O’Brien, 2011). 
 Synthetic Polymers: To date, polymers have seen limited clinical application, 
advances in the field of polymer chemistry have seen the versatility of these 
materials being extended to tissue engineering. With controlled degradation rates 
and biocompatibility, the use of polymers such as polycaprolactone (PCL), poly-
lactic acid (PLA), poly-glycolic acid (PGA), and their copolymers PLGA, as 
well as polyether-ether ketone (PEEK) and poly-methyl methacrylate (PMMA) 
have been summarised in a number of excellent reviews (Cui, Yin, He, & Yao, 
2004; Goonoo, Bhaw-Luximon, Bowlin, & Jhurry, 2013; Hallab et al., 2001; 
Holland & Mikos, 2006; Dietmar W. Hutmacher, 2000; Molera, Mendez, & 
Roman, 2012; Rezwan, Chen, Blaker, & Boccaccini, 2006; Schieker, Seitz, 
Drosse, Seitz, & Mutschler, 2006). 
Only a number of synthetic polymer products exist that are appropriate for 
clinical situations. Cortoss (Orthovita Inc.), OPLA, Immix (Osteobiologies Inc.) 
are some of the few products available (Nandi et al., 2010). Also, AlloSource’s 
AlloFuse is a DBM-copolymer composite and delivered as a putty (American 
Association of Tissue Banks, 2010). In non-structured materials, polymers offer 
little biological or mechanical value and therefore their use as a bone graft 
substitute has been limited. 
Recent advances in the use of polymers for bone regeneration have focussed on 
using advanced manufacturing processes to design intricate ECM-like scaffolds, 
combining structural integrity with advanced internal architectural features to 
maximise tissue regeneration. Polymers are generally more readily processed 
and fabricated into complex and detailed biology-mimicking structures, owing 
to their relatively low melting point, than other biomaterials such as metals and 
 14 Chapter 2: Literature Review 
ceramics. Alongside their biocompatible and biodegradable properties and easy 
combination into composites, polymer biomaterials show much promise as 
effective scaffolding biomaterials for bone regeneration. Furthermore, polymers 
have been used extensively as drug delivery mechanisms; this will be discussed 
further in the Biological Stimulus section.  
 Biological Stimuli: It should be noted that most of the aforementioned 
biomaterials are used as ‘scaffolding’, or replacement ECM, to provide the 
appropriate microenvironment for cell proliferation and migration. However, 
more advanced regeneration solutions are incorporating cells, growth factors and 
other signalling molecules, either via direct injection, hydrogel carriers or more 
advanced delivery solutions, to promote and stimulate rapid tissue growth. 
The use of growth factors for tissue growth stimulation has been widely 
recognised as a key component in bone regeneration. However, there have been 
growing issues about dangerous side effects caused by the use of certain growth 
factors in clinically available grafting substitutes. Off-label use of products 
containing Bone Morphogenetic Protein (BMP) has led to speculation about the 
products' safety (Ong et al., 2010; Tannoury & An, 2014). BMP, a known bone 
formation-inducing protein, has shown substantial pre-clinical and clinical 
success compared to grafting (Burkus, Gornet, Dickman, & Zdeblick, 2002; 
Burkus, Sandhu, & Gornet, 2006; Burkus, Transfeldt, Kitchel, Watkins, & 
Balderston, 2002). Product doses, however, are often supra-physiological and 
carry side effects such as potential nerve injury, ectopic bone formation and a 
significantly increased risk of cancer (Tannoury & An, 2014). Subsequently, 
controlled or delayed release systems are being extensively investigated to 
minimise doses and costs, and improve patient outcomes (Hosseinkhani, 
Hosseinkhani, Khademhosseini, & Kobayashi, 2007; Su et al., 2012; Takahashi, 
Yamamoto, Yamada, Kawakami, & Tabata, 2007; Yamamoto, Takahashi, & 
Tabata, 2006). Bock et al. have developed a method of encapsulating BMP 
particles in polymer microspheres through electro-spraying. The microspheres 
are delivered to the defect site in combination with a biodegradable scaffolds and 
as the polymer spheres slowly dissolve, BMP is released in a controlled manner 
into the defect site to stimulate bone regeneration (Bock, Woodruff, et al., 2014; 
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Bock, Woodruff, Hutmacher, & Dargaville, 2011; Bock, Dargaville, Hutmacher, 
& Woodruff, 2011; Bock, Dargaville, & Woodruff, 2014).  
The use of cells incorporated within the scaffolds has been shown to enhance 
osteoinduction and improve bone regeneration. Cells can either be taken from 
the patient (autologous) or another donor (allogenic), although a preference has 
been shown towards the use of autologous cells due to their intrinsic 
compatibility (Cancedda, Dozin, Giannoni, & Quarto, 2003). Mesenchymal 
Stromal Cells (MSCs) are often used as they are multipotent and naturally 
differentiate into a variety of skeletal tissues and have been widely used in bone 
and cartilage regeneration strategies, as discussed further in section 2.3.3.  
2.1.2 Scaffold Porosity and Vascularisation 
It is well-understood in the literature that porosity and pore size of tissue 
engineering constructs for bone regeneration play a vital role in the success of the bone 
healing process (Hollister, 2005; Karageorgiou & Kaplan, 2005). Biomaterial 
scaffolds serve as an artificial ECM to facilitate cell interactions and must therefore 
successfully mimic the naturally occurring bone morphology. The pores, or spaces, 
within a scaffold allow for the proliferation and migration of cells, facilitating the 
growth and development of the tissue. In a study by Kuboki et al, solid and porous 
hydroxyapatite scaffolds for BMP delivery were implanted into a rat model. After 2 
weeks of subcutaneous implantation, the porous scaffolds showed osteogenesis while 
the solid scaffolds “inhibit[ed] vascular formation and proliferation of mesenchymal 
cells, preventing bone and cartilage formation” (Y Kuboki et al., 1998). Since this 
study, many other studies have similarly concluded that porosity is a critical factor in 
osteogenesis and recognised the need for highly controlled pore sizes (Amini, Adams, 
Laurencin, & Nukavarapu, 2012; Coathup et al., 2012; Ki et al., 2008; Sanzana et al., 
2014). 
Furthermore, porosity is required for the success of cell-seeding protocols to 
ensure effective distribution and infiltration of the scaffolds during in vitro 
investigations or pre-culturing before in vivo implantation. Without sufficiently porous 
scaffolds, cells are unable to be distributed throughout the scaffold, and furthermore, 
a lack of full cell culture media penetration can inhibit cell development from 
starvation of key nutrients and oxygen (Thevenot, Nair, Dey, Yang, & Tang, 2008).  
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A key physiological requirement for the regeneration of bone tissue is 
vascularisation for the delivery of oxygen and movement of nutrients throughout the 
tissue. During the process of bone regeneration, vascular networks will rapidly form 
throughout the tissue to maintain cell function, delivery nutrients in and remove waste. 
This has been evidenced by investigations which show that small pore sizes instigate 
hypoxic conditions and osteochondral growth before osteogenesis, because the ability 
for vascular channels to grow in small pore networks is limited (Figure 3a). Larger 
pores, however, have been shown to allow for rapid blood vessel development which 
leads to direct bone formation, albeit over a longer time frame (Karageorgiou & 
Kaplan, 2005; Y Kuboki, Jin, & Takita, 2001; Yoshinori Kuboki, Jin, Kikuchi, 
Mamood, & Takita, 2015). There is wide recognition that it is important to incorporate 
well-defined vascular channels within controlled pore geometry to optimise tissue 
infiltration, proliferation and migration as well as to assist in direct osteogenesis 
(Figure 3b) (Bae et al., 2012; Griffith & Naughton, 2002; Murphy & Atala, 2014).  
 
Figure 3 Examples of cell growth on various cross-hatch structured tissue engineering constructs. (a) 
Fine fibres and very small pores often lead to hypoxia and insufficient nutrient/oxygen supply and 
waste removal; (b) fine fibres but larger pore sizes facilitate adequate cell attachment without risk of 
starvation; and (c) large pores with large fibres inhibit cell interactions and hinder tissue development. 
Scale bar = 100µm 
 
Considering the above parameters, the mechanical properties of scaffolds for 
bone regeneration must also be matched to the local defect site, ensuring that risks of 
re-fracture or implant failure are minimised. However, scaffolds fabricated with large 
pores (and therefore large void regions) tend to have weaker mechanical properties 
and diminished structural support while small pores maintain the overall structural 
integrity of the scaffold (Karageorgiou & Kaplan, 2005). The trade-off between 
porosity and mechanical support has been recognised as a significant challenge and 
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the optimisation and balance of these two parameters is necessary to achieve successful 
biomimicry (Hollister, 2005; Dietmar W. Hutmacher, 2000). 
Priority has also been placed on mimicking the bone morphology and structure 
to improve tissue integration. The cortical and trabecular components of bone are 
understood to have vastly different porosities and mechanical responsibilities (see 
Section 2.1) and their parameters have been investigated by a number of experimental 
studies (Cooper, Matyas, Katzenberg, & Hallgrimsson, 2004; Keaveny, Morgan, 
Niebur, & Yeh, 2001). To date, however, little research has been published in this area, 
highlighting a significant gap in the literature. In comparison to multi-zonal cartilage 
structures, which have been extensively developed (Jeon, Vaquette, Theodoropoulos, 
Klein, & Hutmacher, 2014), bone scaffolds with multiple zones corresponding to the 
host tissue’s natural porosity and mechanical strength have been suggested as the next 
generation of advanced tissue engineering constructs and will require extensive 
investigation in the future (Sathy et al., 2015). 
2.1.3 Biodegradation 
Scaffold biodegradability is vital to the tissue regeneration process. By allowing 
the migration and proliferation of cells which occupy the defect site at a rate 
commensurate with the scaffold degradation, the morphological and physiological 
requirements of the defect site can be gradually and completely restored. The 
biological and chemical processes associated with the degradation and resorption of 
various biomaterials has been expertly reviewed in a number of articles. Sheikh et al. 
summarised the mechanisms of calcium phosphate-based biomaterial degradation, 
concluding that “cement dissolution, disintegration, and fragmentation/particle 
formation followed by phagocytosis through macrophages and osteoclast mediated 
resorption is responsible for the biodegradation and resorption of [calcium phosphates] 
when implanted in vivo” (Sheikh et al., 2015). For synthetic polymer-based scaffolds, 
such as those fabrication from PLA, PGA and PCL, concerns have been raised as to 
high local acidic conditions produced by the degradation by-products (Niiranen, 
Pyhältö, Rokkanen, Kellomäki, & Törmälä, 2004; Rezwan et al., 2006; S. Yang, 
Leong, Du, & Chua, 2001). The use of bioglass composites has been suggested as a 
means of stabilizing the pH of the microenvironment (Boccaccini, 2003).  
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Clinically, the benefits of biodegradable bone graft substitutes as opposed to 
permanent metal devices have been recognised in the orthopaedic sphere for a number 
of key reasons: 
1. Biodegradable implants eliminate the need for revision or removal surgery 
which provides both financial savings for the clinic as well as reduced 
psychological impact on the patient. A 2005 UK study revealed that over 90% 
of patients considered additional surgeries as the largest drawback of their 
treatments involving metal implants (Mittal et al., 2005). Without additional 
surgeries, patients can experience decreased costs and recovery time, reducing 
the impact and stress of their treatment (Amini et al., 2011). 
2. Biodegradable tissue engineered implants minimize the risk of infection from 
grafting procedures as well as metal toxicity issues. They also provide a platform 
for drug and growth factor delivery to the defect site to assist the healing process 
and prevent infections (Amini et al., 2011). 
3. Biodegradable implants have shown to have decreased stress shielding 
compared with permanent implant devices (Huiskes, Weinans, & van 
Rietbergen, 1992; Juutilainen, Pätiälä, Ruuskanen, & Rokkanen, 1997). 
4. Compared to metallic implants, biodegradable solutions do not interfere with 
imaging techniques (Amini et al., 2011). 
Therefore, it is likely that biocompatible materials will play an increasingly 
important role in the development of the next generation of bone loss treatments.  
2.1.4 Scaffold fibre geometry  
The relative importance of the specific geometry of the fibres within ECM-
micking scaffolds, regardless of the fabrication technique, has seen increased attention 
in the literature on bone tissue engineering. Heavily related to porosity, the size and 
shape of fibres heavily affects the biological efficacy of the overall structure. 
It has been demonstrated in vitro that cells have enhanced attachment, 
proliferation and migration on tissue engineered constructs with fibres of similar 
morphology to natural ECM, composed of a micro-scale network of collagen and 
minerals, compared to larger or disordered structures where their natural processes for 
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attachment and proliferation are limited by the surrounding construct design (Balguid 
et al., 2009; M. Chen, Patra, Warner, & Bhowmick, 2007; Tong, Wang, & Lu, 2012).  
Furthermore, for biodegradable scaffolds, greater cell proliferation and more 
rapid infiltration throughout the construct results in the scaffold fibres being entirely 
surrounded by cells, instigating more rapid scaffold degradation and replacement of 
natural tissue. Ultimately, this results in faster defect healing and improved patient 
outcomes. 
2.1.5 Scaffold Viability Assessment 
With many studies over the last few decades investigating new bone regeneration 
devices using combinations of the biomaterials and scaffold characteristics discussed 
above, a number of in vitro characterisation techniques have been developed to assess 
the biological suitability of the scaffolds for tissue regeneration, prior to pre-clinical 
analysis. Analysis techniques include performing morphological assessment of the 
constructs using Scanning Electron Microscopy (SEM) or micro-Computed 
Tomography (µCT) while biological performance is assessed using cell studies. Cells 
are seeded onto the constructs and incubated and cultured with cell culture media 
accordingly. Live/Dead staining can then be used to assess positive cell attachment 
and distribution throughout the scaffold, typically indicating live cells in green and 
dead cells in red where the dye can penetrate the ruptured membranes of the dead cells. 
Assays, such as MTT or Alkaline phosphatase (ALP) activity assays, are used to assess 
the activity of the cells over a number of time points, indicating their growth rate and 
proliferation throughout the scaffold (Causa et al., 2006). The morphology and 
attachment of cells is also a crucial factor in the biological performance of tissue 
engineered constructs, demonstrating the interaction of cells within the construct and 
their ability to attach and migrate. Therefore, nuclear and cytoskeleton staining, such 
as the DAPI (4',6-diamidino-2-phenylindole)/Phalloidin stains, can be used to 
fluorescently indicate the nuclei and cytoskeletons (Ristovski et al., 2015) and to show 
how well spread a cell is on the scaffold. Among many others, these techniques allow 
for qualitative and quantitative analysis of the scaffolds, indicating their viability and 
biological constructs. 
Ultimately, the aim of the development of novel tissue engineered constructs is 
to devise successful tissue regeneration devices which provide benefits beyond the 
current gold standard treatments available. Therefore, in vivo studies, where the 
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performance of the constructs can be assessed in a biological environment similar to 
that of the human body, are essential. Often, the performance of novel tissue 
engineering devices is compared to that of defects with no intervention (negative 
control), grafts or other commercially available products (positive control). The 
success of the constructs, therefore, can be directly compared to other treatment 
options. 
2.1.6 Implant Requirements  
Collating the factors considered above for the use and development of bone graft 
substitute materials, a complete picture of the requirements for a successful implant 
design can be formed: 
1. The scaffold design must be patient-specific and suitably mechanically robust 
depending on the load-bearing requirements of the defect site. 
2. Suitable biomaterials must be used, with biocompatible and biodegradable 
properties. The addition of bioactive ingredient such as cells and growth factors 
enhances scaffold efficacy. 
3. The microenvironment within the scaffold must be highly controlled, with 
optimal pore size and fibre geometry for cellular attachment, proliferation and 
migration, as well as infrastructure for the development of vascularisation. 
 
 
Figure 4 Key requirements for successful bone tissue engineering constructs, 
as summarised from the literature review. 
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2.2 BIOFABRICATION 
2.2.1 Additive Manufacturing Techniques 
In recent years, bone tissue engineering groups have extensively investigated 
various scaffold fabrication techniques. 3D printing, or more accurately additive 
manufacturing, has shown great promise as a successful bone tissue engineering 
fabrication technique. Additive manufacturing involves the layer-by-layer fabrication 
of 3D objects using computer design and control. It offers a range of benefits over 
other fabrication techniques, including the ability to produce highly customised and 
intricately designed scaffolds with controlled architecture, porosity and fibre geometry 
using a range of biomaterials and bioactive ingredients. In 2015, Meskó summarised 
twelve of the most successful medical breakthroughs using 3D printing in an article 
published on 3dprintingindustry.com (Meskó, 2015). His list included: 
 Tissue with blood vessels, citing the work of Prof Jennifer Lewis from 
Harvard University on incorporating dissolving ink blood vessel 
networks in multi-cell tissue structures (Rojahn, 2014); 
 Low-cost prosthetic parts, referencing a number of research groups and 
companies who have developed techniques for producing customised 3D 
printed prostheses; 
 Medical models of patient body parts for surgical planning and practice. 
These have been introduced into the clinic with world-wide success and 
will be discussed further in section 2.3.1; and 
 Ear cartilage, stepping into the bionics realm by incorporating lab-grown 
cartilage in the shape of an ear with electronic components to restore or 
improve hearing (Molitch-Hou, 2013).  
Within the scope of bone biofabrication, a number of the major printing 
techniques showing significant potential for translation into routine clinical use will 
be discussed in terms of their printing resolution, materials used, recent advances and 
efficacy in a clinical setting (as shown in Figure 5).  
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(a) Stereolithography         (b) Selective Laser Sintering 
 
          (c) Fused Deposition Modelling       (d) Melt or solution extrusion 
Figure 5 Schematic diagrams of additive manufacturing techniques commonly used in biofabrication. 
Reproduced with permission from Mota, Puppi, Chiellini, & Chiellini, 2015. Copyright © 2012 John 
Wiley & Sons, Ltd. 
 
Stereolithography 
SLA is one of the original 3D printing techniques, developed in the 1980s. A 
concentrated UV light beam is focused onto a platform just beneath the surface of a 
vat of liquid photopolymer. The incident light causes polymerisation (or cross-linking) 
to create a solid. The beam progressively moves across the surface to create a 2D layer 
before a piston lowers the platform and the next layer can be created at the surface of 
the liquid, typically in approximately 100um increments. The solid object is then 
cleaned and cured in a UV oven (Stevens, Yang, Mohandas, Stucker, & Nguyen, 
2008).  
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There are a limited range of materials used in SLA and particular care must be 
taken to ensure structural and chemical integrity of those materials throughout the 
process. However, successful production of bioactive scaffolds through this process 
has been reported in the literature. For example, aqueous polyethene-glycol (PEG) 
hydrogel solutions can be used in SLS to produce complex structures with bioactive 
ingredients embedded (Cooke, Fisher, Dean, Rimnac, & Mikos, 2003) and the use of 
bioceramic scaffolds fabricated using SLA has also been widely investigated (Bian et 
al., 2012; Du, Asaoka, Ushida, & Furukawa, 2014). A significant challenge in SLA is 
that it requires photoindicators and radicals which may become cytotoxic during 
processing (Chia & Wu, 2015).  
Stereolithography is a very fast additive manufacturing techniques with the 
ability to create complex structures at a resolution of 14-150µm (Mota et al., 2015). 
However, it has limited appeal to tissue engineers as a fabricating technique due to its 
very high equipment and consumable costs, and limited biocompatibility. 
Selective Laser Sintering 
SLS uses a similar operating set up to SLA but instead of UV light on photo-
sensitive liquid polymer, a laser is used to bind powder particles. This heats portions 
of the power to above the glass transition temperature and fuses particles to create 
shapes. The laser scans across the top of the powder vat before a piston holding the 
printed part lowers and a new layer of powder is brushed across the top, leaving a new 
layer to be sintered. Heat treatment is also required post-print to secure loose layers. 
The primary benefit to SLS is the ability to create overhangs without the use of support 
structures, since unbound particles are supported by un-sintered powder until they can 
be bound at the top of the structure (Chia & Wu, 2015). 
PCL and a combination of polyether ketone and hydroxyapatite are commonly 
used materials for SLS fabrication and the resolution can be between 50µm and 
1000µm (Lohfeld et al., 2010; Tan et al., 2003; Wiria, Leong, Chua, & Liu, 2007). 
A number of polymer and polymer-composite scaffolds have been developed for 
bone regeneration. PCL and PCL/β-TCP powders have been used to create bone-
regenerating scaffolds using SLS (Doyle, Lohfeld, & McHugh, 2015). In vitro studies 
have demonstrated that SLS scaffolds fabricated using PCL are biocompatible with 
MSCs (Mazzoli, Ferretti, Gigante, Salvolini, & Mattioli-Belmonte, 2015) while 
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poly(vinyl alcohol)/calcium silicate (CaSiO3) (Shuai, Mao, Han, & Peng, 2014) and 
calcium silicate ceramic  (Feng et al., 2014) scaffolds showed increased bioactivity 
and cytocompatibility with MG-63 cells. Furthermore, other research groups have 
investigated a number of scaffold strut orientations on the uptake of chondrocyte- or 
collagen-infused gels and dynamic mechanical properties (C.-H. C.-H. Chen et al., 
2014). The successful use of bioactive glass in SLS has also been widely reported, 
including recent in vitro biocompatibility tests with MG-63 cells (Cao, Yang, Gao, 
Feng, & Shuai, 2015) and in vivo testing of SLS scaffolds in combination with a 
dicalcium phosphate dehydrate as a BMP-2 carrier to regenerate critical-sized long 
bone defects in rat femurs (W.-C. Liu et al., 2014). A subdermal implantation of 
gelatin- and collagen-surface treated SLS PCL scaffolds in mice showed successful 
regeneration of cartilage (C.-H. Chen et al., 2014). 
Fused Deposition Modelling 
Fused Deposition Modelling (FDM) is one the most common additive 
manufacturing techniques and is a leading technology in the rapidly growing 
commercial 3D printing market (Hern, 2014). Due to its accessibility, FDM is 
pioneering technology within bone tissue engineering for the production of polymer 
scaffolds with well-defined architectures. FDM was first developed is the late 1980s 
and commercialised in the early 1990s (Chee Kai Chua, Kah Fai Leong, 2003).  This 
technique typically involves the controlled extrusion of molten material, such as 
polymer or metal, which then cools and hardens onto the deposition platform. Precise 
stepper or servo motors move an extrusion needle across a stage or move the stage 
itself, layering 2D patterns on top of one another to produce 3D structures. 
Polymer FDM platforms typically use low-cost materials such as Acrylonitrile 
Butadiene Styrene (ABS) and Polylactic acid (PLA), however, they also can fabricate 
with a wide variety of biocompatible materials such as Polycaprolactone (PCL) 
(Korpela et al., 2013). The extruded fibres generally have a diameter of the order of a 
few hundred micrometres, making this technique suitable for the production of tissue 
engineering constructs with well-defined and appropriately sized pores.  
FDM has been well established as a potential biofabrication technique (D W 
Hutmacher, 2000; Hutmacher et al., 2001; Schantz, Brandwood, Hutmacher, Khor, & 
Bittner, 2005; Zein, Hutmacher, Tan, & Teoh, 2002), particularly for load-bearing 
bone (Berner et al., 2013; Jensen et al., 2015), total disc replacement (van Uden, Silva-
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Correia, Correlo, Oliveira, & Reis, 2015), osteochondral defects (Schumann, 
Ekaputra, Lam, & Hutmacher, 2007; Swieszkowski, Tuan, Kurzydlowski, & 
Hutmacher, 2007) and cranial defects (Castilho et al., 2014; Jensen et al., 2014; 
Rohner, Hutmacher, Cheng, Oberholzer, & Hammer, 2003). However, in vitro studies 
have shown that the fibre diameters and resulting surface-to-volume ratios produced 
using traditional FDM techniques is not as ideal for cell proliferation as techniques 
capable of much smaller fibre networks (Muerza-Cascante, Haylock, Hutmacher, & 
Dalton, 2015). This observation has led to the development of advanced techniques 
such as electrospinning which combines the high-precision and rapid printing 
capability of FDM with much finer and more precise fabrication resolution (Muerza-
Cascante et al., 2015). 
Electrospinning 
Electrospinning has seen a recent surge in popularity as there is growing 
recognition of its application to the production of scaffolds for bone regeneration. 
Electrospinning is the extrusion of a liquid such as molten polymer through a needle 
in the presence of a large electric potential (as shown in Figure 6). The polymer can 
be liquefied by a solvent or melted and deposited via a computer-controlled platform. 
PCL is one of the most commonly used materials in electrospinning due to its 
biocompatibility, biodegradability and low melting point (Woodruff & Hutmacher, 
2010). Melt-electrospinning has been used more favourably over solution 
electrospinning in biofabrication because melt-electrospinning does not require 
cytotoxic solutions (Dalton, Joergensen, Groll, & Moeller, 2008). Also, one benefit of 
melt-electrospinning over other extrusion-based techniques such as FDM is its ability 
to produce substantially finer polymer fibres, ranging from approximately 270nm to 
500µm in diameter (Muerza-Cascante et al., 2015). This ultimately improves fibre 
attachment and cell proliferation throughout the scaffold. 
Melt-electrospinning has been developed as a leading fabrication technology at 
the Queensland University of Technology and has gained international attention for its 
revolutionary approach to tissue engineering (Brown et al., 2012; Brown, Dalton, & 
Hutmacher, 2011; Farrugia et al., 2013; Dietmar W. Hutmacher & Dalton, 2011; 
Ristovski et al., 2015). This thesis will focus on the design of scaffolds using melt-
electrospinning as the favoured additive manufacturing fabrication technique. 
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2.2.2 Melt-Electrospinning 
 
Figure 6 Schematic diagram of melt-electrospinning machine, demonstrating the use of the water 
heater to melt the material, syringe pump for controlled extrusion onto the moving collector plate and 
high voltage power supplies delivering the large electric field for micro-scale fibre extrusion.  
 
A water heater and jacket are used to pump water around a needle containing the 
polymer. Depending on the melting properties of the material used, the water 
temperature can be adjusted to improve viscosity. A computer controlled syringe pump 
provides a controlled force on the syringe plunger. A deposition platform has x, y, and 
z mobility and its computer controlled mechanisms will be discussed in further detail 
in section 2.2.3. Finally, positive and negative high-voltage power supplies are 
attached to the needle and platform respectively. The strong electric field results in the 
formation of an electrohydrodynamic phenomenon called a Taylor cone on the head 
of the needle. This phenomenon is due to the electrostatic force being in static 
equilibrium with the surface tension of the polymer. When the surface tension of the 
cone is exceeded, a very thin and stable jet of liquid is formed and deposited on a 
collector plate where it rapidly cools and solidifies (Dietmar W. Hutmacher & Dalton, 
2011). 
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In the tissue engineering literature, in particular biofabrication, the relative 
importance of fibre diameter and spacing within scaffolds has been subject to 
considerable discussion. Largely, fabrication techniques have tended toward micron-
resolution scaffold architecture because cells prefer micron-scale networks for 
attachment, proliferation and migration, as discussed in section 2.1.2. Biomimicry 
theory concurs, offering a range of arguments for requiring polymer scaffold structures 
to match the natural ECM network geometry (Khan, Yaszemski, Mikos, & Laurencin, 
2008). Since melt-electrospinning allows the fabrication of highly controlled 
structures of micro- to nano-resolution fibres and interconnected pores, a growing 
number of research labs around the world are investigating bone regeneration 
techniques using this technology. 
Many in vitro studies have confirmed the biological success of electrospun 
scaffolds by culturing and analysing cell behaviour, particularly using the MC3T3-E1 
mouse osteoblast precursor cell line (Erisken, Kalyon, & Wang, 2008; H. Lee, Ahn, 
Choi, Cho, & Kim, 2013; Ren et al., 2014). In vivo success has been demonstrated 
through implanting electrospun hydroxyapatite/collagen/chitosan nanofibre scaffolds 
in combination with induced pluripotent stem cell-derived mesenchymal stem cells 
(iPSC-MSCs), which initiates osteogenesis (Xie et al., 2015). Using a hybrid solution- 
and melt-electrospinning set up, silk fibroin nanofibres were interwoven with a PCL 
microfibre scaffold and trialled in a rabbit calvarial defect model.  After 8 weeks, this 
showed significantly more bone formation than pure PCL microfibre scaffolds (B. S. 
Kim et al., 2015).  
While melt-electrospinning offers many advantages over other fabrication 
techniques, layer stability has severely limited the size and versatility of the scaffolds 
able to be fabricated. The maximum achievable height of melt-electrospun scaffolds 
has been restricted by increasing disorder in fibre deposition due to electric charge 
build up within the scaffold itself. As a consequence, Ristovski et al. have reported the 
fabrication of ordered scaffolds of up to 1.5mm by optimising the voltage distribution 
between the needle and collector plate (Ristovski et al., 2015). Similarly, other studies 
have investigated the effects of a number of other operational parameters to increase 
scaffold stability and fibre order (Brown et al., 2014, 2011).  
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2.2.3 Machine Control Language 
The movement of the collector plate in the melt-electrospinning set up (Figure 
6) controls the deposition of fibres in ordered 3D structures. The collector plate is 
attached to a motorised translation slide assembly (Velmex, USA) which can move in 
the x, y and z planes. This is connected to a controller (ECG 5-axis board) which is 
driven by Mach3 software (ArtSoft, Division of Newfangled Solutions LLC, 
Livermore Falls ME, USA). The input for operating set ups such as this is ‘g-code’, 
which is one of the most widely used programming languages for numerical control. 
G-code instructs the motorised slides to translate according to a certain set of 
parameters, namely defining a location to which it should move as well as the speed 
and path it should take. Therefore, to print a 3D structure, g-code instructs the 
deposition of material in a guided 2D pattern in the x-y plane before translating a ‘step’ 
in the z plane and depositing another 2D layer on top of this. Using repeat commands 
and other basic programming functionality, customised g-code can control the 
fabrication of complex 3D structures.  
G-code can be manually written with sufficient knowledge of the programming 
language and instructions of the movement of the slides however, as with many manual 
coding tasks, this can be tedious and automated g-code generating software programs 
have been developed. Often, these programs automatically include the 3D printer’s 
design program, such as the Makerbot Desktop software which controls the widely 
available Makerbot FDM printers (MakerBot Industries LLC, 2016). The software 
allows for input of 3D models in standard STL or OBJ format. The graphic user 
interface allows the simple manipulation of the object before the model is ‘sent’ to the 
printer via an inbuilt ‘slicer’ and g-code generator. As the name suggests, the ‘slicer’ 
separates the 3D model into a series of 2D images. Each is filled with the appropriate 
g-code to guide the deposition of material in the required shape and then recompile 
with z-translation steps in between each layer. Similarly, many other commercially 
available printers come with their own 3D modelling software, which automatically 
translate 3D models into the appropriate guidance commands in the form of g-code for 
the fabrication of customised objects. Depending on the printer, support material may 
be required to support fabricating structures which overhang parts of the model. 
Functionality is also inbuilt into the ‘slicer’ and g-code generator to accommodate for 
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these situations, often utilising a secondary printing nozzle to print dissolvable support 
material.  
This process can be replicated for melt-electrospinning machines, albeit at a 
more basic level. There is no all-in-one software system for melt-electrospinning 
machines to translate 3D models into g-code due to one major hurdle which has to date 
severely limited the design capability of these printers: melt-electrospinning machines 
have no ability to turn off the extrusion of material. As a result, all patterns must be 
completed using a continuous thread with minimal overlaps (Figure 7). For the 
automated generation of g-code, this is a significant programming hurdle. 
 
  
Figure 7 Melt-electrospinning machines must maintain constant extrusion due to 
the interaction of the polymer with the high electric field. 
 
To demonstrate the difference in programming the printing of complex shapes, 
Figure 8 shows the pattern that could be recognised by a FDM printer versus that which 
a melt-electrospinning machine would require. For a doughnut-shaped object, the 
FDM g-code generator could identify a series of vertical stripes, some continuous and 
others broken, to fill the required shape. The melt-electrospinning machine would 
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require the continuous infill of the left side, top and right side of the doughnut before 
having to loop back and fill the bottom section. While this solution is easily identified 
by the human mind, programming this in an automated system is a complex challenge. 
     
Figure 8 Schematic diagram of the way (a) an FDM g-code regenerator might ‘view’ the required 
solution to filling in a complex shape such as a doughnut (grey) versus (b) the printing pattern 
required by a melt-electrospinning machine. The FDM printer can print a series of continuous and 
discontinuous stripes across the shape, stopping the flow of material across the hole and continuing on 
the other side. However, the melt-electrospinning machine cannot stop and start and therefore must 
print the left side, top and right side, before doubling back to fill in the missing bottom section. 
 
The interpretation of the scaffold layers by the g-code generator relies on a 
“collide and turn” system whereby the placement of fibres is guided by the program 
‘pointer’ moving across the image. The program begins by separating the white 
background pixels from non-white image pixels. The pointer is placed initially on one 
side of the image, pointing in a direction determined by the operator. When the pointer 
first collides with the edge of the shape, it turns and moves briefly to the side before 
moving back across the image. This builds up an array of lines, connected by short 
perpendicular lines to maintain a continuous thread. The coordinates for this path are 
then translated into g-code which guides the deposition of material during the melt-
electrospinning process. Each layer is individually interpreted by the g-code 
generation program, determining the method for filling each layer before connecting 
them with appropriate z-translation steps in between to fabricate the object layer-by-
layer. 
While the x-y design of the scaffold is determined by the generation of g-code to 
fill each 2D slice, the z design requires interpolation techniques to create accurate 
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designs. CT data can be represented in a series of ‘sliced’ images, where the average 
signal over a certain region is displayed on each slice. For clinical data, the slicing 
thickness is often 2mm. However, melt-electrospinning machines print at layer spaces 
equal to the fibre thickness, often as small as 50µm. Therefore, the information lost 
between each slice must be approximated such that a rendering with higher z-
resolution can be sliced into many more layers. Figure 9 shows the various 
interpolation options for filling each 2mm gap between CT images with 40 50µm-
spaced melt-electrospun layers. Therefore, the interpretation of data, not only in the x-
y plane is a significant consideration in the design process for irregular-shaped 
scaffolds. 
 
Figure 9 Use of interpolation to approximate the z- scaffold geometry. (a) demonstrates the case 
where the information in the lower slice is extrapolated over the 2mm until the new slices changes the 
design. This is known as ‘piecewise constant interpolation’. (b) shows the use of the linear 
interpolation, connecting corresponding regions of the lower and upper slice with a straight line. (c) 
shows the use of a spline interpolation to smoothly approximate the content between successive CT 
slices. This is calculated using a series of polynomial functions. 
 
Furthermore, considering the design limitation without complex coding 
protocols, studies have focused on a number of melt-electrospun scaffold designs for 
bone regeneration. These include the production of non-woven sheets of randomly 
oriented fibres, and ordered scaffolds, often with a cross-hatch layer pattern and 
tubular scaffolds.  
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Figure 10 Melt-electrospinning has been used to fabricate a variety of scaffold architectures including 
(a) (d) non-woven mats (Reproduced from Nivison-Smith & Weiss, 2011), (b) (e) ordered cross-hatch 
scaffolds (Brown et al., 2011) and (c) (f) tubular meshes (Reproduced from Brown et al., 2012, 
Copyright © 2012 John Wiley & Sons, Ltd.).  
 Random-fibre scaffolds: Circumventing the need for controlled deposition of 
fibres, the fabrication of non-woven mats of melt-electrospun fibres was one 
of the earliest applications of electrospinning in tissue engineering (Lannutti, 
Reneker, Ma, Tomasko, & Farson, 2007). Using a much larger tip-to-collector 
plate distance, a high level of electric charge instability allows for the random 
deposition of fibres onto the collector plate. The random orientation of sub-
micron fibres, however, has been shown to inhibit cell infiltration; Pham et al. 
demonstrated that a minimum fibre diameter of 4µm was required for the 
scaffold to have pore sizes of at least 20µm which can promote cell infiltration 
and proliferation (Pham, Sharma, & Mikos, 2006). Furthermore, 
interconnected pores are not achievable through random deposition which, as 
discussed in section 2.1.2, can limit the viability of the scaffold by restricting 
the diffusion of nutrients and development of blood vessels. However, to utilise 
the enhanced cell seeding and proliferation properties of the micron- to nano-
scale fibre networks, with the added benefits of large pores for cell migration, 
hybrid scaffolds have been developed by combining large, structurally 
supporting scaffolds with a large fibre diameter and interconnected pores with 
a b c 
d e f 
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electrospun meshes (G. Kim, Son, Park, & Kim, 2008; Moroni, de Wijn, & van 
Blitterswijk, 2008; G.-H. Yang, Kim, & Kim, 2015).  
Non-woven scaffolds are not often fabricated with well-defined external 
architecture due to the randomness of the fibre deposition process; rather the 
mats are cut or biopsy punched into the required size for analysis. 
 Ordered scaffolds: A number of techniques have been employed to transition 
the fabrication of scaffolds using electrospinning from non-ordered mats to 
highly ordered structures. Liu et al. (2005) used two bar magnets either side of 
the collector plate to maintain a 0.2T magnetic field which aligns the deposition 
of the charged fibres normal to the magnet surfaces (Y. Liu, Zhang, Xia, & 
Yang, 2010). Also, the use of a ‘direct writing’ approach has driven the ability 
to create organised scaffolds with well-defined pore structures, 
interconnectivity and fibre diameters. By optimising the collector plate speed 
with respect to the material jet being electrospun, the material can be drawn 
out in a continuous thread and deposited layer-by-layer to create 3D lattices. 
These cross-hatch structures feature optimised pore sizes and interconnectivity 
for cell proliferation and migration along with micron-scale fibres for cell 
attachment. They have been trialled in a number of in vitro and in vivo studies 
(Muerza-Cascante et al., 2015).  
A traditional design for ordered scaffolds has been in cross-hatch patterned 
squares, as the machine control required for the movement of the collector plate 
can be guided by reasonably simple g-code (Hochleitner et al., 2015; Powell et 
al., 2014; Ristovski et al., 2015). While 90° cross-hatch has been the more 
widely used scaffold design, alternative fibre directional geometries have also 
been investigated (Brown et al., 2011). 
 Mesh tubes: Tubular melt-electrospun scaffolds have been developed by melt-
electrospinning onto a spinning mandrel instead of a collector plate. The needle 
is directed up and down along the axis of the mandrel while it spins, facilitating 
the ‘wrapping’ of the fibres around the mandrel, creating a tube layer-by-layer. 
These have been used in a number of bone regeneration applications, 
particularly because of its ability to mimic long bone defects (Berner et al., 
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2012; Brown et al., 2012; Kolambkar, Boerckel, et al., 2011; Kolambkar, 
Dupont, et al., 2011). 
While the geometry of the tube is largely governed by the diameter and length 
of the mandrel on which it is spun, the only machine control programming 
required is to guide the rotational speed of the mandrel and movement of the 
needle or mandrel along the length of the tube.  
With advanced tissue engineering techniques tending towards fabrication 
devices which facilitate more ordered and controlled constructs, more sophisticated 
computer control systems are required to guide the fabrication of these structures. The 
Biofabrication and Tissue Morphology group at QUT has overcome this programming 
issue by developing proprietary g-code generation software which has the ability to 
recognise multiple sections of complex shapes and ‘fill’ them accordingly. By 
recognising areas which could not initially be connected with a single continuous fibre, 
the program automatically adds an additional section of infill to complete the pattern. 
For example, any regions of a shape which, on the same vertical line, have more than 
two areas separated by at least one gap are identified and the program generates the g-
code to fill the top section before returning to the lower area (see Figure 8). The 
operating details of this program will be described in section 3.1.1. 
Melt-electrospinning is a highly promising additive manufacturing technique for 
creating biofabrication scaffolds. It offers substantial biocompatibility advantages over 
other fabrication techniques, validated by an abundance of in vitro and pre-clinical 
analysis and it is likely to assist the clinical translation of biofabrication for bone 
engineering. With the creation of new g-code generating software, this technology can 
now be brought one step closer to clinical use by having the ability to create complex 
structures. This provides a significant opportunity for applications in many areas, 
particularly orthopaedic treatments. 
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2.3 3D PRINTING AND MODELLING IN ORTHOPAEDICS  
3D printing and modelling techniques have been rapidly adopted by orthopaedic 
surgeons to assist in the creation of 3D models of patient injuries, modelling straight 
from their medical scan data, as well as then 3D printing these models for surgical 
planning and intra-operative guidance. With the rapidly growing 3D printing market, 
printers can be purchased cheaply and operated using widely-available FDA-approved 
software systems. As such, research is now catching up with justifying and improving 
the clinical use of these devices, often retrospectively analysing the impact and 
effectiveness of these techniques for surgical assistance (Huang, Xiang, et al., 2015; 
J.-C. Yang et al., 2014). In this section, a number of major applications of 3D printing 
and modelling within the clinical orthopaedic sphere will be discussed.  
2.3.1 Models for Surgical Planning 
3D printed models, based on a patient’s medical scan data, can be readily 
produced through a segmentation process from the CT data followed by 3D 
reconstruction and finally fabrication by a 3D printer. Laser-based 3D printers, 
particularly SLS, are widely used due to their ability to produce complex structures at 
a reasonable resolution and speed as well as handling overhangs without the need for 
support material (Berry et al., 1997). Comparatively, FDM offers cheap and effective 
fabrication (Debarre, Hivart, Baranski, & Déprez, 2012; Maheshwaraa, 
Arumaikkannu, & Gowri, 2008). In a number of key orthopaedic applications, surgical 
models have been developed and assessed for their impact; 
Hip/Pelvis Surgery: 3D models were successfully fabricated for the “assessment, 
classification and preoperative planning of acetabular fractures” whereby models from 
twenty patients undergoing acetabular fracture treatments were fabricated and 
successfully used by the surgeons to reduce variability in fracture classification 
(Hurson et al., 2007). Similar models were created and successfully implemented in 
arthroplasty and dysplastic hip surgeries (Dhakshyani, Nukman, & Abu Osman, 2011; 
Popov & Onuh, 2009).  
Spinal Surgery: Many studies have recognised the significant assistance given by 
anatomically-customised 3D modelling and printing  in spinal surgery, particularly in 
the context of scoliosis treatments (Xiao et al., 2008; M. Yang et al., 2015) as well as 
lower back pain, as reviewed by Deoghare et al. (Deoghare & Padole, 2005). The 
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accuracy of fabricating patient-specific vertebral models was investigated by Ogden et 
al., concluding that the vertebral models produced using their segmentation 3D 
printing technique were sufficiently accurate compared to direct measurements of 
cadaveric spine as 3D renderings (Ogden, Ordway, Diallo, Tillapaugh-Fay, & Aslan, 
2014). Recently, a retrospective study assessed the effectiveness of 3D printed models 
during the treatment of 49 patients suffering from atlantoaxial instability and 
concluded that the use of the personalised 3D printed models greatly assisted operative 
procedures (J.-C. Yang et al., 2014). 
Maxillofacial/Cranial/Dental Surgery: The use of 3D printed models in this area has 
been recently reviewed, furthering the evidence that these techniques greatly assist 
with surgical planning and intra-operative procedures, which improves patient 
outcomes (Farré-Guasch et al., 2015; Nayar, Bhuminathan, & Bhat, 2015; Winder & 
Bibb, 2005). Specifically, 3D printed models have been used in the treatment of cleft 
palate (Gong & Yu, 2012) as well as anterior skull base lesions (Hammer, Zizelmann, 
& Scheufler, 2010) with great success.  
2.3.2 Surgical Guides, Tools, Templates 
In addition to the direct fabrication of patient-specific bone models from medical 
scan data, surgical guides, tools and templates can be developed to assist operational 
procedures. Many different cutting guides and screw templates in particular have 
resolved many clinical challenges associated with orthopaedic treatments. Drill 
templates for pedicle screw placement have been widely developed, with many 
research groups reporting successful cadaveric and clinical trials (Hu et al., 2013; Lu 
et al., 2009; Owen, Christensen, Reinhardt, & Ryken, 2007; Salako, Aubin, Fortin, & 
Labelle, 2002; Takemoto et al., 2015). Furthermore, Huang et al. have 3D printed 
customised navigational drill templates for the treatment of 6 patients with 
complicated tibial plateau fractures (Huang, Hsieh, et al., 2015). The use of additive 
manufacturing has revolutionised the ability of surgeons to perform routine treatment 
operations with a high degree of accuracy and low costs through the use of customised 
guiding equipment and tools. 
2.3.3 Patient-Specific Scaffolds for Bone Regeneration 
Finally, the third major application of additive manufacturing in orthopaedics is 
the fabrication of customisable and anatomically accurate implants. As discussed, this 
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can broadly be split into non-regenerative implants such as those discussed in the 
‘metals’ section of section 2.1.1, as well as regenerative scaffolds to instigate tissue 
regeneration, which is the focus of this thesis. 
Already, scaffolds have been trialled in pre-clinical models to investigate the 
efficacy of various biomaterials, cells, growth factors and treatment processes. Here, 
two case studies will be presented, detailing the current models for (a) long bone defect 
treatments and (b) osteochondral defects for treatment of osteoarthritis.  
Case Study 1: Long Bone Defects 
Long bone defect models have been widely employed to examine the success of 
3D printed scaffolds in load-bearing areas. A ‘critical size’ defect is defined as a region 
where, without medical intervention, the tissue defect would never completely heal 
over the natural lifetime of the host (Spicer et al., 2012).  Segmental long bone defects 
of a standardised length are surgically created to simulate critical size defect sites and 
are treated with experimental or control techniques to assess the efficacy of a particular 
technology. After explantation, histological analysis is used to assess bone formation 
within the defect site and to observe healing patters. Mechanical testing is also 
employed to assess the mechanical properties of the regenerated tissue. 
Many different scaffold-cell-growth factor combinations have been used by 
research groups around the world in small animal models such as rats, rabbits and 
mice.  Studies have also used larger sheep tibial models, which Pearce et al. (2007) 
argue more closely match human morphological and physiological conditions. 
It should be noted that many treatments developed by research groups share a 
common thread: polymer microfibre scaffolds, with the inclusion of bone-matching 
biomaterials such as TCP or hydroxyapatite, along with MSCs and BMP in various 
delivery systems. Ultimately, the motivation for these trials is to ensure pre-clinical 
success before clinical translation. In the future, 3D printers could be installed in 
operating theatres to produce custom designed scaffolds for immediate implantation 
into the patient. These scaffolds may be made from polymers, natural bone materials, 
signalling molecules and cells, as show in Table 1. These would be used as an 
alternative to bone grafting for trauma treatments, spinal fusion, tumour excision or 
treatment of malunion or non-union fractures. 
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Table 1 Studies demonstrating successful pre-clinical trials using 3D printed scaffolds for the 
regeneration of critical size long bone defects. The animal, bone, size of defect, scaffold material and 
use of cells and growth factors (GFs) are noted. 
Title Reference Animal Bone Size Scaffold Cells GFs 
Tailored star poly (ε-
caprolactone) wet-spun 
scaffolds for in vivo 
regeneration of long bone 
critical size defects 
(Dini et al., 
2015) 
Rabbit Radius 20mm 
PCL-
hydroxyapat
ite 
- - 
Oxidized alginate 
hydrogels for bone 
morphogenetic protein-2 
delivery in long bone 
defects 
(Priddy et al., 
2014) 
Rat Femur  8mm 
PCL 
Nanofibre 
mesh 
 
Oxidized 
alginate 
hydrogels  
BMP-2 
Establishment of a 
bilateral femoral large 
segmental bone defect 
mouse model potentially 
applicable to basic 
research in bone tissue 
engineering. 
(Xing et al., 
2014) 
Mice Femur  2mm DBM BMSCs - 
Efficacy of 
prevascularization for 
segmental bone defect 
repair using β-tricalcium 
phosphate scaffold in 
rhesus monkey. 
(Fan, Zeng, 
Wang, Zhu, 
& Pei, 2014) 
Rhesus 
Monkey 
Tibia 20mm 
cylindrical 
β-TCP 
ceramic 
(Biocetis 
Company) 
MSCs  - 
Bone regeneration in a 
massive rat femur defect 
through endochondral 
ossification achieved with 
chondrogenically 
differentiated MSCs in a 
degradable scaffold 
(Harada et al., 
2014) 
Rat Femur 
5mm, 
15mm 
PLGA  MSC-DCs - 
Autologous vs. allogenic 
mesenchymal progenitor 
cells for the reconstruction 
of critical sized segmental 
tibial bone defects in aged 
sheep 
(Berner et al., 
2013) 
Sheep Tibia 30mm PCL-TCP MPCs - 
A Tissue Engineering 
Solution for Segmental 
Defect Regeneration in 
Load-Bearing Long Bones 
(Reichert et 
al., 2012) 
Sheep Tibia 30mm PCL-TCP MSCs BMP-7 
Biomimetic tubular 
nanofibre mesh and 
platelet rich plasma-
mediated delivery of 
BMP-7 for large bone 
defect regeneration 
(Berner et al., 
2012) 
Rat Femur 8mm 
PCL + CaP 
coating 
- 
BMP-7 
+ 
platelet 
rich 
plasma 
An alginate-based hybrid 
system for growth factor 
delivery in the functional 
repair of large bone 
defects 
(Kolambkar, 
Dupont, et al., 
2011) 
Rat Femur 8mm 
PCL 
electrospun 
nanofibre 
mesh tube 
alginate 
hydrogel  
BMP-2 
 
Case Study 2: Osteochondral defect 
With total joint replacement surgeries making up the majority of surgical 
procedures undertaken by orthopaedic surgeons, the regeneration of cartilage and bone 
for use in treating osteoarthritis has been of significant interest to researchers. Articular 
cartilage lacks significant regenerative capability and when left untreated, in such 
cases as following trauma or degenerative conditions such as osteoarthritis, 
pathological changes to both the cartilage and surrounding bone can result in 
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diminished joint mobility and patient quality of life (Jeon, Vaquette, Theodoropoulos, 
Klein, & Hutmacher, 2014). While common treatments include grafting and total joint 
replacement to replace the failing cartilage, regenerative techniques are also being 
developed in parallel to bone tissue engineering. Highly ordered 3D printed scaffolds, 
in combination with hydrogels, growth factors and mechanical stimuli, are used to 
replicate the natural characteristics (Jeon, Schrobback, Hutmacher, & Klein, 2012; 
Klein et al., 2010; Mauck et al., 2000). 
To trial these tissue engineered constructs, animal models have been established 
to examine the efficacy of each solution, ranging from smaller rabbit models to those 
which have more human-like joint properties. A number of key studies have been 
described below. 
Table 2 Animal studies for the development of osteochondral defect regenerative solutions. 
Title Reference Animal Scaffold Cells 
Evaluation of Cartilage Repair by 
Mesenchymal Stem Cells Seeded 
on a PEOT/PBT Scaffold in 
an Osteochondral Defect 
(Barron et al., 
2015) 
Rabbit 
polyethylene-oxide-
terephthalate/polybutylene-
terephthalate (PEOT/PBT) 
MSCs 
Differential Cell Viability of 
Chondrocytes and Progenitor 
Cells in Tissue-engineered 
Constructs Following 
Implantation into Osteochondral 
Defects 
(Emans et al., 
2006) 
Rabbit 
Poly (ethylene 
glycolteraphthalate) and poly 
(butylene terephthalate 
(PEGT/PBT) 
Chondrocytes 
A Novel Osteochondral Scaffold 
Fabricated via Multi-nozzle Low-
temperature Deposition 
Manufacturing 
(L. Liu, Xiong, 
Zhang, & Jin, 
2009) 
Rabbit PLGA + Coll 1 MSCs 
Multiphasic construct studied in 
an ectopic osteochondral defect 
model 
(June E Jeon et 
al., 2014) 
Rat PCL Chondrocytes 
 
The use of these regenerative solutions aims to ease the demand for donor tissue 
and minimise the requirement for total joint replacements where the tissue could be 
directly treated and restored to its natural function. 
These two case studies demonstrate the pre-clinical success of many 
regenerative strategies. However, each model uses a surgically prepared defect site for 
reproducibility. In a clinical setting, a biofabrication solution will need to have the 
ability to produce scaffolds to fit a variety of bones in the body, sometimes in a 
composite approach with other structures like cartilage. This ‘patient-specific’ element 
to biofabrication is one of the key novel components of this research area of this thesis.  
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2.4 SUMMARY AND IMPLICATIONS 
The emerging role of bone tissue engineering and the use of additive 
manufacturing in the medical sphere has been discussed in this literature review. The 
well-understood bone regeneration process, coupled with advancements in the 
development of more sophisticated biomaterials and fabrication techniques, offers a 
new era in treating bone loss, and the use of 3D printed scaffolds as a replacement for 
bone grafts offers a range of benefits, including customisation.   
The biological and design requirements for these scaffolds have been discussed, 
highlighting the importance of biomaterial choice, including the addition of bioactive 
ingredients (section 2.1.1), porosity and vascularisation (section 2.1.2) as well as 
biodegradability (section 2.1.3). These were summarised in section 2.1.4, offering a 
literature-derived proposal for a successful implant for bone regeneration. Most 
importantly, the use of additive manufacturing as the fabrication technique in 
biofabrication offers the ability to rapidly create implants which provide each 
individual patient with a customised solution for their bone defect treatment. As such, 
the design process of patient-specific implants based on medical scan data will be the 
motivation for this research.  
To date, research has focussed on known defect site models for pre-clinical trials 
and patient-specific scaffolds have not yet been designed for fabrication on melt-
electrospinning machines. However, clinical expectations dictate that each scaffold 
should be customised and patient-specific. No two people or injury site will be exactly 
the same. Therefore, this research project focusses on bridging the gap between the 
ability for QUT’s Biofabrication and Tissue Morphology (BTM) Group to produce 
successful bone regeneration scaffolds that meet the clinical need for patient-specific 
architecture. A method for designing patient-specific scaffolds based on clinical CT 
scan data for melt-electrospinning fabrication will be developed. 
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Figure 11 This research project intends to bridge the gap between the successful pre-clinical studies 
showing the efficacy of melt-electrospun PCL scaffolds for bone regeneration and the clinical 
expectation that scaffolds must be patient-specific in design. Graphic from YCIS Blog, 2014. 
 
Research Advances 
• Melt-electrospinning 
• Successful  in vitro and 
in vivo models 
Clinical Demands 
• Patient-specific 
architecture 
• Timely manufacturing 
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Chapter 3: Research Design 
This chapter describes the design methods developed to achieve the aims stated 
in section 1.2 of Chapter 1. Section 3.1 discusses the proposed method developed in 
the study, the stages by which the method was implemented, and the use of clinical 
data to validate the method; section 3.2 details the participants in the study; section 3.3 
lists all the instruments used in the study and justifies their use; and section 3.4 briefly 
discusses how the success of the results were validated. Finally, section 3.5 discusses 
the ethical considerations of the research and limitations. 
3.1 METHOD AND PROCEDURES 
3.1.1 Method 
A method was developed to translate CT scan data into melt-electrospinning 
instructions for the appropriately shaped scaffolds, which was then applied to a number 
of clinical case studies. To satisfy the two aims of this project (section 1.2), a method 
for designing scaffolds of a single density (evenly distributed fibres) was firstly 
developed. Following the successful implementation of this method, the interior 
architecture of the scaffold design was reconsidered to incorporate multiple regions of 
density (porosity/fibre spacing) to more closely mimic the cortical and trabecular bone 
as required for the specific defect site. This section outlines the general method while 
sections 3.1.2, 3.1.3 and 3.1.4 detail the specific procedures for each of the case 
studies. 
In general, the scaffold design method that was implemented is as follows: 
 
This stage was undertaken by Nicholas Green at the RBH. Surgical consultation 
was vital in completing this stage of the investigation, which ensured that the 
treatment procedure plan would include osteotomy, realignment and placement of 
fixation devices. After the 3D model was corrected to virtually treat the defect, the 
requirement for additional grafting material could be ascertained. 
CT Scan Data                3D STL Model 
1 
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The scaffold design stage was undertaken as part of this research project using a 
variety of 3D modelling software. Subtraction and lofting tools were used to isolate 
and design the required scaffold. 
 
The 3D model of the scaffold was sliced using Creation Workshop software 
(Envision Labs, Mankato MN, USA). The program produced a series of .png images, 
sliced at a “thickness” determined by the user. This was selected to match the melt-
electrospinning layer thickness so each image corresponded to one layer fabricated 
using the printer. 
The images were automatically output as .png files with a black background and 
white silhouette showing the segment of the scaffold design. 
 
The slices were batch converted to .bmp files and a number of post processing 
filters were applied, including an inversion so the image would be black with white 
background, as well as crop and scale tools so the images were 512px x 512px. 
 
The series of slice images were input into the g-code generator, via the input file 
where each image and its fill parameters could be set, namely the fibre spacing. In all 
cases, the ‘cortical bone’ components were filled with 500µm fibre spacing and the 
‘trabecular bone’ components were filled with 1mm fibre spacing.  
A scaling parameter, r, is required by the g-code generation program to instruct 
how the program should interpret the pixels into distance. Therefore, a ratio of how 
   3D STL Model                Scaffold Design  
2 
               Scaffold Design                    Slice Series 
3 
            Slice Series Image Processing 
4 
                   Slice Series                     G-code 
5 
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many pixels within the image correspond to 1mm is defined by the following formula:
           𝑟 =
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 (𝑝𝑖𝑥𝑒𝑙𝑠)
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 (𝑚𝑚)
               (1) 
Therefore, for each scaffold, a measurement was taken, often across the length of the 
scaffold both on the 3D model and one of the images. The number of pixels over this 
distance was divided by the number of millimetres to which this corresponded. 
The input file for the g-code generator comprised of a series of command lines 
corresponding to each image. 
“FileName.bmp”r5.0FcO0H50R0G0B0A500M1000m100TmB0S0 
The file name is called (red), followed by the pixel-to-millimetre ratio, r (blue). 
The fill orientation (F, green) is set to ‘crosshatch’ (c) and the initial orientation of fill 
(O, purple) set to 0°. The height (H, light blue) is set to 50. The orange RGB value for 
the region to be filled is set to R=0, G=0, B=0 which corresponds to black. This would 
be altered to R=255, G=0, B=0 where the image was red. The average (A), maximum 
(M) and minimum (m) fibre spacings (green) can be altered in the value of microns. 
And finally, the type (T), bend (B) and sharpness (S) parameters were not utilised in 
this investigation and set to their default settings. 
Each image layer of the scaffold was therefore called in order so the g-code 
generator would produce g-code for the bottom layer upwards. Each alternate layer 
was set with an orientation (O) of 90° so the crosshatch pattern would be completed. 
The program was then executed to generate unique g-code for each scaffold. 
The g-code could then be viewed in a Mathematica (Wolfram, Champaign IL, 
USA) program which imported a file of the coordinates generated for the g-code and 
draws connecting lines between each to show the path of the g-code (Appendix B). 
 
Finally, although not a direct aim of this project, the g-code was tested on a melt-
electrospinning machine to fabricate the scaffolds as a means of determining the 
suitability of the g-code for the production of patient-specific designs. The operating 
parameters for the printing process are outlined in Section 3.3. 
 
                G-code                    Melt-electrospinning 
6 
 46 Chapter 3: Research Design 
To include regions of varying density, the CT data was re-evaluated to identify 
the dense cortical bone structures which appear as higher intensity in the CT images. 
Since the cortical and trabecular regions were not directly mapped in the original 
corrected 3D model, an approximate depth of the cortical bone throughout the 
scaffolds was measured using ImageJ and translated onto the 3D scaffold model.  
Subsequently, a secondary 3D model of the cortical bone was created, sliced and post 
processed into a different colour on a transparent background (stages 4-5). These 
images were then input into the g-code generator along with the original images to 
create dual-density scaffolds.  
 This method was implemented in three case studies: 
 Skull Model – Photo structure from motion (SFM) of a model skull with defect 
 Femur Defect – CT data from the RBH 
 Patella Defect – CT data from the RBH 
3.1.2 Procedure for Case 1 
Case Outline 
A method for using open-source software and mobile phone cameras as cheap 
and accessible scaffold design tools, as demonstrated in the VC STEM Camp 2015 
workshop, will be described. Specifically, the principles of Structure from Movement 
(SFM) imaging will be applied to translate a number of 2D images, taken from 
different locations, into a 3D model. 3D information can be approximated through the 
recognition of corresponding points on an object and the presumed movement between 
images. The use of a common background assists the reconstruction process, often 
undertaken by complex algorithms. By assuming that an object with respect to its 
environment isn’t moving and the only movement between images is by the camera 
itself, a sufficient number of 2D images can be used to construct a 3D image. A ‘point 
cloud’ is constructed of all the points identified in each image and corresponding 
points, through triangulation, can more accurately estimate the location from which 
each picture was taken. 
This process can be applied on many scales, from stereo micro-imaging on 
biological samples to 3D reconstructions of ancient monuments through helicopter-
assisted surround imaging. In this part of the project, an iPhone was used to image the 
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defective bones from multiple angles. In this investigation, an example of a skull with 
a large fracture was used. This type of fracture could have been caused by significant 
blunt force trauma to the left parietal bone. The resultant comminuted fracture would 
have required immediate medical attention and the reconstruction of the bone, most 
likely with the assistance of a combination of grafting material, plates or fixation 
devices. Additionally, the patient would also undergo soft tissue and brain injury 
treatments. 
Data Acquisition  
80 photographs were taken at intervals rotating 360° around the model at three 
different heights. These images were imported into Autodesk 123D Catch (San Rafael 
CA, USA) and a capture was created, assembling the photos into an approximate 3D 
model. This was then transferred into Autodesk 123D MeshMixer (San Rafael CA, 
USA) for editing. 
The background and table were removed from the model, and the model was 
‘made solid’ to ensure that there were no inconsistencies or gaps in the skull model. 
Finally, the 3D model was imported into Autodesk 123D Design (San Rafael CA, 
USA) where the scaffold could be designed. A tangent plane to the defect area was 
created and, using a spline tool, the exterior design of the scaffold was sketched onto 
the plane, according to where the edge of the defect area appeared on the skull model. 
This sketch was extruded into the centre of the skull, creating a prism with the cross 
sectional design matching the required scaffold. 
Scaffold Design 
To finish the scaffold design, a ‘complete’ skull was created in Meshmixer. This 
was achieved by mirroring the non-defective side of the skull onto the defective side. 
This complete skull model was then imported into Design and aligned with the 
defective skull. A Boolean subtraction operation was then performed to remove the 
unwanted regions of the scaffold prism. The ‘intersect’ operation subtracted the 
defective skull from the complete skull, yielding only the region where the two models 
were different: the missing bone section within the defect. Then, this region which 
intersects with the scaffold prism was left, with all the remaining, non-intersecting 
elements deleted. This revealed the scaffold design. The interior surface of the scaffold 
was then adjusted by subtracting material which intersected with the complete skull 
which had to be moved approximately 6mm into the skull. This ensured a smooth, 
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6mm thick scaffold with its exterior and interior faces matching the required geometry 
of the skull into which it was being inserted. 
Scaffold Slicing 
Given the geometry of the defect area and necessary replacement implant, the 
cross-sectional design was uniform in the z direction and therefore the scaffold could 
be designed based on one layer design repeated a number of times as long as it was 
designed based on the curved section of the skull rather than the linear distance 
between edges of the defect area. Therefore, the final 3D model of the scaffold, saved 
as an STL file, was sliced using Creation Workshop. A representative image from 
middle of the slice series was selected to use as the scaffold design and cropped, rotated 
and the colour inverted. Further edits to the exterior design of the scaffold to make the 
design more accurate. A number of exterior dimensions were directly measured from 
the bone model, in particular the distance along the curved surface of the skull along 
the length of the defect area, and used to guide the scale and size of the scaffold. These 
measurements were used to determine the scaling parameter, r, required in the next 
step. Also, a ‘front on’ image of the defect area was used to better define the scaffold 
edges so it would more accurately fit the model. 
G-code Generation 
The image was input to the g-code generator software to create two different 
cross-hatch design g-codes, one corresponding to a dense, closely spaced fibre pattern 
for cortical bone and another larger fibre spacing pattern to emulate trabecular bone. 
The g-code was completed by adding in repeat commands for the fabrication of 80 
‘trabecular’ layers to create a single-density (SD) scaffold. A dual-density (DD) 
scaffold g-code was also created by programing the fabrication of 20 ‘cortical’ layers, 
20 ‘trabecular’ layers and another 20 ‘cortical’ layers. 
Where the g-code would connect various regions of the scaffold with diagonal 
lines intersecting the design, these commands were manually altered so the path would 
go around the edge of the scaffold and recommence from an edge, rather than moving 
straight across the scaffold and interfering with the fill pattern (see section 5.2.4). 
Scaffold Fabrication 
The two scaffolds, as described above, were fabricated according to the 
operating parameters detailed in section 3.3.  
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3.1.3 Procedure for Case 2 
Case Outline (Ethical Exception #1500000868)  
A patient was admitted to the Orthopaedic Unit at the RBH after suffering a 
malunion of the right femur. Following an injury a number of years earlier, the femur 
was incorrectly aligned after healing and the bone improperly formed. In the course of 
treatment, the patient underwent x-ray and CT scans to assess the injury site and to 
assist surgical planning. At the Orthopaedic Unit, a 3D model of the patient’s entire 
left leg was constructed. Under the guidance of an orthopaedic surgeon, the location 
of osteotomy was identified and the model was used to determine the corrective 
rotation required to restore alignment from the femoral head towards the knee. The 
corrective osteotomy was performed and a nail and screws were used to stabilise the 
bone. The correction to the femoral shaft, however, resulted in a wedge-shaped void 
in the bone. This was identified by the surgeon as a potential application for the use of 
a 3D printed scaffold which could regenerate the bone in that area. Therefore, this 
patient was selected for this research project so the scaffold design protocol could be 
applied to a clinically relevant case. 
Scaffold Design 
The corrected 3D model, supplied as an STL file, was provided by the 
Orthopaedic Unit staff, along with the original CT data, supplied as a DICOM file. To 
design the scaffold, the corrected femur model was imported into Solidworks. Two 
sketching planes were created against the proximal and distal surfaces of the defect 
area and the exterior shape of the femur was sketched onto each. A loft was created 
between the two planes to form a solid region filling the void. Also, the interior margin 
of the medullary cavity was sketched on each plane and a subtraction loft was 
performed to extract the unwanted volume from the centre of the scaffold design. The 
completed wedge-shaped scaffold was exported to Autodesk Design and the distal face 
aligned to the horizontal x-y plane. 
Scaffold Slicing 
The aligned scaffold design was imported into Creation Workshop for slicing. A 
slicing thickness of 50µm was approximated based on the average melt-
electrospinning fibre diameter of previous studies. The output images were saved as 
.png files and opened in Irfan View for post-processing. The images were batch 
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inverted, scaled so the smaller dimension was equal to 512px and then cropped into a 
512x512px square. 
G-code Generation 
While the model was based on the corrected STL model of the femur, a scaling 
parameter for the melt-electrospinning program was still required. Therefore, two 
features on opposite sides of the distal surface of the scaffold were selected and 
measured in Solidworks to reveal the distance in millimetres and well as in ImageJ so 
the number of pixels this distance corresponds to could be found. The scaling 
parameter, r, was then determined by Equation 1. 
𝑟 =
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 (𝑚𝑚)
𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 (𝑝𝑖𝑥𝑒𝑙𝑠)
         (2) 
 
Finally, the image series was input into the g-code generation software with a uniform 
fibre spacing of 500µm selected for each layer. This yielded the g-code for the SD 
scaffold design.  
Dual Density 
To include regions of varying density, the original CT scan data was re-evaluated 
to determine the content of cortical bone to trabecular bone in each cross section. Since 
the corrected 3D model provided by the Orthopaedic Unit did not distinguish between 
these two bone components, the depth of cortical bone within the exterior boundary of 
the femur cross section was measured in a number of locations and translated into the 
scaffolds 3D model design. By cropping the model according to these measurements, 
a second 3D scaffold model, only corresponding to the cortical bone region, was 
generated. This model underwent the slicing and processing protocol as described 
above, with the output slice images rendered red on a white background so they could 
be differentiated by the g-code generator. Also, a second set of ‘trabecular bone’ only 
layers were created by subtracting the cortical regions from the full black image. 
 Since it is challenging for a continuous polymer thread to print regions of 
different fibre spacing within the same layer, two layer configurations were developed 
and trialled: 
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 A – Separate regions within the same layer: 
Trabecular bone region with sparse fibre spacing 
followed by cortical bone region with dense fibre 
spacing, printed in the same layer. 
 B – Overlaying more dense layers: Full slice 
corresponding to both cortical and trabecular bone 
with a sparse fibre spacing overlaid with the 
cortical bone layer at smaller fibre spacing. 
Scaffold Fabrication 
Four scaffolds were fabricated according to the operating parameters in section 
3.3. Firstly, an SD scaffold was fabricated. Secondly, 10 layers from each of the DD 
scaffolds were fabricated so they could be easily analysed macroscopically and 
microscopically. These were compared to an SD scaffold of the same 10 layers. Layers 
13-22 were selected as representative of the cross-section of the scaffold.  
3.1.4 Procedure for Case 3 
Case Outline (Ethical Exception #1500000868) 
Another patient was treated in the Orthopaedic Unit at RBH after suffering 
malunion of a complex patella fracture. The original injury was treated approximately 
9 months prior with a number of nails to align the pieces. However, the patient reported 
limited flexion of the leg of just 90°. Following x-rays and CT scans, the cause was 
identified as severe patella malunion. To treat the injury, staff in the Orthopaedic Unit 
created a 3D model of the injury site and, with surgeon consultation, an operative 
procedure was determined to extract the screws, realign the fragments, remove a 
portion of bone from within the malunion site and permanently fix the pieces together 
with two screws. In the process of the pre-operative planning, it was identified that a 
region of bone from the central anterior surface of the base was missing and could 
potentially be treated using a 3D printed scaffold. 
Scaffold Design 
A similar procedure to Case 2 was undertaken for this patient. The corrected 3D 
model was supplied as an STL file along with the original DICOM CT data. Also, a 
3D model of the contralateral patella region was supplied for comparison. Both models 
were imported into Autodesk Design and aligned such that the patellae were in the 
 
Figure 12 Dual-density 
scaffold layer 
configurations. 
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same location. A subtraction tool was used to isolate the region of the corrected patella 
that was missing compared to the whole patella. The surrounding model was deleted, 
leaving just the segment missing from the middle of the base of the patella.  
It was noted that in order to print the thin layer, the object would need to be 
oriented on its side in order to minimise overhangs during the printing process. The 
lateral surface of the scaffold was therefore aligned to the horizontal x-y plane. 
Scaffold Slicing 
The model was then saved as an STL file and imported into Creation Workshop 
for slicing. Using a much thinner slicing thickness of 20µm to emulate the predicted 
layer height during printing, a series of black and white .png images were exported 
and post-processed in Irfan View. The images were cropped, scaled to 512 x 512px 
and inverted so the scaffolds slices were black on a white background. 
G-code Generation 
Finally, these images were input to the g-code generation software which filled 
each layer with the appropriate fibre spacing g-code. 
Dual Density 
The original CT scan data was again consulted to identify the dense cortical bone 
region of the patella. By altering the threshold of a CT slice, directly traversing the 
theoretical location of the scaffold, the contrasting density was easily identified and 
measured along the anterior surface on which the scaffold would sit. These 
measurements were translated into the 3D model of the scaffold and the scaffold was 
cropped accordingly. The cortical 3D model was then sliced and processed as per the 
original procedure. Also, a second set of ‘trabecular bone’ only layers were created by 
subtracting the cortical regions from the full black image. 
As per Case 2, two different layer configurations were trialled to assess the best 
method for creating multiple density regions. 
 Separate regions within the same layer: Trabecular bone region with 
sparse fibre spacing followed by cortical bone region with dense fibre 
spacing, printed in the same layer 
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 Overlaying layers: Full slice corresponding to both cortical and trabecular 
bone with a sparse fibre spacing overlaid with the cortical bone layer at 
smaller fibre spacing. 
Scaffold Fabrication 
The height of the scaffold (width, if positioned anatomically) was measured to 
be 14.28mm, which is significantly higher than the maximum height of ordered 
printing currently achievable by melt-electrospinning machines. Therefore, only the 
first 200 layers were fabricated. A single-density scaffold, with 1mm fibre spacing was 
printed. Then, the first 100 layers were printed with (a) SD 1mm spacing; (b) cropped 
‘trabecular bone’ and ‘cortical bone’ in the same layer; and (c) an entire layer of 
‘trabecular bone’ with ‘cortical bone’ layers overlaid. This was then repeated for the 
SD and two DD configurations for the first 10 layers of the design. 
The scaffolds were fabricated according to slightly modified operating 
parameters than those used previously due to the geometry of the scaffold design. 
Because it was very small, very accurate fibre placement was required to ensure 
adequate controlled deposition to form the scaffold. The tip-to-collector plate distance 
was set to 5mm, syringe pump flow decreased to 40µL/hr and needle voltage decreased 
to +3.5kV. Also, the translational speed of the collector plate was decreased to 
500mm/min. 
3.1.5 Scaffold Microscopy Imaging 
Regions of the scaffolds were imaged using a Light microscopy (Zeiss Axio 
Imager A2, Germany). Images were taken using a smart phone camera directed down 
the eyepiece and the scale was calibrated against a ruler. 
3.1.6 Scaffold Measurements 
For the three case studies, measurements from the original defect model (either 
physical or 3D model), the 3D scaffold design model and fabricated scaffolds were 
taken for comparison. A number of dimensions on each of the scaffolds were selected 
and measurements taken using either measurement tools within the 3D modelling 
programs or Kincrome 150mm Digital Vernier Callipers. Also, the average fibre 
diameter was measured by calibrating the measurement tool in ImageJ against the scale 
bar of the scaffold micrographs and taking 5 measurement of the diameter within the 
ROI. These were averaged with standard error. 
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3.2 PARTICIPANTS 
Three anonymous participants were used in this study, selected by Dr Kevin 
Tetsworth. Each participant was treated at the RBH in the Orthopaedics Unit for 
various defects and was selected based on their suitability for this study. During 
treatment, each of the patients suffered from critical sized bone loss and was treated 
according to normal practices. For the purposes of this study, it was post-operatively 
assessed by the surgeon that each of the participants could have required a 
biofabricated scaffold to treat regions of bone loss if the technology were clinically 
available. This made them suitable participants in this study.  
3.3 INSTRUMENTS 
A custom-made melt-electrospinning machine was used for the fabrication of 
the scaffolds and set up according to previously published methods (Ristovski et al., 
2015). PCL pellets were obtained from Perstorp (PCL, Capa 6430®, Perstorp UK Ltd.) 
and placed in a 2mL plastic syringe with a 21 gauge needle. This was loaded into the 
melt-electrospinning heated water jacket, set to 73°C and left for 12 hours overnight 
to melt and remove air bubbles. The syringe pump (AL-1000, World Precision 
Instruments) was set to an extrusion rate of 45uL/hr. The needle was connected to the 
positive high-voltage power supply, set to +5kV while the collector plate was 
connected at -3.5kV. The tip-to-collector plate distance was set to 10mm. The 
connector plate was attached to motorised slide assembly (Velmex, USA), with a stage 
speed of 800mm/min and controlled by Mach3 software (ArtSoft, USA). 
The slides were translated according to the g-code designed in this project. 
3.4 ANALYSIS 
The efficacy of the developed method was assessed based how time efficient it 
was to produce the models as well as their accuracy compared to the model created 
from the original CT data. Comments were also made on where improvement can be 
made to enhance the design process and its utility as a patient-specific scaffold design 
protocol for use in pre-clinical and imminent clinical trials. 
Since the fabrication of the scaffolds was not a direct aim of this research project, 
they were only used to validate the efficacy of the design protocol for creating 
multiple-density scaffolds, rather than undergoing rigorous characterisation as per 
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previously published works (Powell et al., 2014; Ren et al., 2014; Ristovski et al., 
2015).  
3.5 ETHICS AND LIMITATIONS 
As human data was being used in this investigation, it required ethics approval 
or an exemption.  An exemption was sought. The QUT University Human Research 
Ethics Committee assessed this research as meeting the conditions for exemption from 
HREC review and approval in accordance with section 5.1.22 of the National 
Statement on Ethical Conduct in Human Research (2007).  
The research team did not obtain a full snapshot of the required demand for 
patient-specific scaffolds to treat bone loss. Rather, the number of participants used in 
this study was chosen based on time constraints and so that the design protocol could 
be sufficiently implemented to validate its success. 
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Chapter 4: Results 
In this chapter, the results of each case study, including the initial data, 
development of scaffold design and g-code visualisation will be shown. Also, 
photographs and microscope images of the fabricated scaffolds including 
measurements will be included.  
Three case studies are presented in this chapter: 
 Section 4.1 – Case 1: Skull Model Defect 
 Section 4.2 – Case 2: Patient Femur Defect 
 Section 4.3 – Case 3: Patient Patella Defect 
Table 3 Fabricated scaffold names and descriptions for the single-density (SD) and dual-density (DD) 
scaffold designs. The appendix location of the g-code for each scaffold has also been indicated. 
Case Scaffold Name 
Layer 
Range 
No. of 
Layers 
Fibre Spacing Appendix 
1 
 
SD Skull Scaffold 
 
1-80 80 Uniform – 1mm C 
DD Skull Scaffold 1-60 
20 
20 
20 
Cortical – 500µm 
Trabecular – 1mm 
Cortical – 500µm 
D 
2 
 
SD Femur Scaffold 
 
1-200 200 Uniform – 1mm E 
 
SD Femur Scaffold 
 
13-22 10 Uniform – 1mm E 
DD Femur Scaffold A 13-22 10 
Cortical – 500µm 
Trabecular – 1mm 
(separate regions per 
layer) 
F 
DD Femur Scaffold B 13-22 10 
Cortical – 500um 
Trabecular – 1mm 
(overlay) 
G 
3 
 
SD Patella Scaffold 
 
1-200 200 Uniform – 1mm H 
 
SD Patella Scaffold 
 
1-100 
1-10 
100 
10 
Uniform – 1mm H 
DD Patella Scaffold A 
1-100 
1-10 
100 
10 
Cortical – 500µm 
Trabecular – 1mm 
(separate regions per 
layer) 
I 
DD Patella Scaffold B 
1-100 
1-10 
100 
10 
Cortical – 500µm 
Trabecular – 1mm 
(overlay) 
J 
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4.1 CASE 1: SKULL  
 
 
 
 
Figure 13 Design process for the skull defect: (a) the skull, (b) the 3D model, (c) the scaffold design, 
(d) slice image, (e) generated g-code, (f) fabricated scaffold. (g) shows the SD scaffold with 
micrographs (h)-(i) showing the fibre structure at x20 magnification. Similarly, an overview of the DD 
scaffold is shown in (j) with micrographs depicting the different layers at x20 magnification. 
  
5cm 5cm 5cm 
2cm 
(a) (b) (c) 
(d) (e) (f) 
2cm 2cm 5cm 
1cm 1mm 
(g) (h) (i) 
(j) (k) (l) 
1cm 
1mm 
1mm 1mm 
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4.2 CASE 2: FEMUR 
 
 
 
Figure 14 Design process for the femur defect: (a) corrected 3D model, (b) use of sketch planes to 
define the outer boundaries of the scaffolds, (c) loft tool used to complete the scaffold, (d) scaffold 
design, (e) generated g-code and (f) fabricated scaffold. Next, overviews of the 10-layer scaffolds for 
SD (g), DD-A (h) and DD-B (i) are shown with micrographs at x20 magnification (j)-(l) 
demonstrating the fibre order for the three scaffolds respectively. 
  
5cm 1cm 1cm 
1cm 1cm 1cm 
(a) (b) (c) 
(d) (e) (f) 
1cm 1cm 1cm 
(g) (h) (i) 
(j) (k) (l) 
1mm 1mm 1mm 
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4.3 CASE 3: PATELLA 
 
 
 
Figure 15 Design process for the patella defect: (a) the original, uncorrected model, (b) the proposed 
treatment plan, (c) the contralateral patella overlaid with the defective patella, (d) the subtracted 
region yielding the scaffold design, (e) generated g-code and (f) fabricated scaffold. Next, overviews 
of the 10-layer scaffolds for SD (g), DD-A (h) and DD-B (i) are shown with micrographs at x20 
magnification (j)-(l) demonstrating the fibre order for the three scaffolds respectively. 
  
2cm 1cm 
1cm 5mm 2cm 
(a) (b) (c) 
(d) (e) (f) 
3cm 
1cm 1cm 1cm 
(g) (h) (i) 
(j) (k) (l) 
1mm 1mm 1mm 
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4.4 MEASUREMENTS 
Table 4 Measurements at various locations for each of the defects to validate the accuracy of printed 
construct size. Each measurement was recorded on the defect model, scaffold model and printed 
scaffold for comparison and the percentage accuracy of the printed measurement compared to the 
model was calculated. 
 
D = scaffold depth 
 
Defect 
Model 
Scaffold Model Printed Scaffold 
A 81.15mm 88.00mm 108% 89.76mm 111% 
B 63.09mm 63.15mm 100% 63.76mm 101% 
C 37.22mm 36.56mm 98% 35.77mm 96% 
D 6.00mm 5.00mm 83% 1.30mm 22% 
 
 
D = cortical bone thickness 
A 44.25mm 44.25mm 100% 67.92mm 153% 
B 38.23mm 38.23mm 100% 37.27mm 97% 
C 2.50mm 2.50mm 100% 3.48mm 139% 
D 9.38mm 9.38mm 100% 3.38mm 36% 
 
D = cortical bone thickness 
A 20.57mm 20.57mm 100% 20.54mm 100% 
B 4.80mm 4.80mm 100% 4.97mm 104% 
C 14.28mm 14.28mm 100% 2.23mm 16% 
D 1.40mm 1.40mm 100% 1.32mm 94% 
 
Table 5 Average diameter of the fibres comprising the SD Skull, Femur and Patella scaffolds. 
 SD Skull Scaffold SD Femur Scaffold SD Patella Scaffold 
Average Fibre Diameter 22.60 ± 0.53µm 27.80 ± 0.66µm 31.80 ± 0.23µm 
 
 
 
A 
B 
C 
A B 
C D 
A 
C 
B 
D 
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Chapter 5: Discussion 
Chapter 5 contains a full discussion, interpretation and evaluation of the results 
in terms of the potential efficacy of the scaffolds as potential bone regeneration 
devices. Firstly, the biological considerations will be discussed in section 5.1, followed 
by the physical design considerations including the use of patient-specific architecture 
and regions of varying density (section 5.2). Recommendations for continued research 
will be outlined in section 5.3 followed by the limitations and challenges of furthering 
this technique towards routine clinical use (section 5.4). 
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5.1 BIOLOGICAL CONSIDERATIONS  
5.1.1 Biomaterials and Biological Ingredients  
The biomaterial chosen for this study was PCL, based on previously published 
studies by our research group identifying its significant promise as a scaffold 
biomaterial for bone tissue engineering constructs. Consistent with current in vivo 
studies, MSCs and BMP as biological stimuli within the scaffold could also be used to 
enhance optimal tissue regeneration. Within our research group, studies are underway 
to combine melt-electrospun mesh scaffolds with MSCs and BMP suspended in 
polymer microparticles to optimise regeneration of long bone defects in sheep. Pilot 
studies are promising.  
5.1.2 Biocompatibility 
While a cell study was not included in this thesis, the biocompatibility of PCL 
scaffolds fabricated using the in house melt-electrospinning machine with the same 
operating parameters has already been assessed in previously published work by our 
own team (Ristovski et al., 2015). Initially, the scaffolds underwent sodium hydroxide 
(NaOH) etching surface modifications to improve surface roughness. A 6mm biopsy 
punch was used to isolate small sections of the scaffolds for culture. Murine calvarial 
osteoblastic cells (MC3T3-E1) were seeded onto the scaffolds with an average 
concentration of 5000 cells/scaffold for proliferation assessment using an MTT cell 
proliferation assay, and 450,000 cells/scaffold for cell morphology analysis using 
DAPI/Phalloidin staining and cell distribution using live/dead staining. The results 
demonstrated successful cell infiltration and attachment with minimal evidence of cell 
death after seven days (Ristovski et al., 2015). 
However, these scaffolds had consistent 90° crosshatch geometry with 500µm 
fibre spacing, while the scaffolds designed in this research had fibre spacing varying 
between 500µm and 1mm. The implications of this have been discussed in section 
5.3.2 describing future research required to optimise the biological function of dual-
density scaffolds. 
5.2 PHYSICAL DESIGN CONSIDERATIONS 
5.2.1 Fibre Diameter 
In the slicing stage of the scaffold design process for the femur scaffold, the fibre 
diameter was approximated to be 50µm and therefore the 3D model was sliced at these 
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increments, assuming that each layer would be fabricated at this z spacing.  However, 
this was substantially larger than the true fibre diameter measured experimentally and 
since each layer rests upon the layer below, each subsequent printed layer no longer 
represented the corresponding pattern at that z height in the model. The entire scaffold 
was therefore “squashed”. As a result, a slicing thickness of 20µm was selected for the 
patella scaffold and was therefore a much more accurate scaffold in the z plane. 
In future experiments, the printing fibre diameter should be accurately 
determined when slicing the design so each layer of the design can be accurately 
fabricated. Furthermore, based on the design, it would be optimal if the fibre spacing 
could be selected on the melt-electrospinning machine to match the input design. 
However, since variation in the fibre diameter produced by the melt-electrospinning 
machine is highly susceptible to changes in the operating configuration, such as 
temperature, extrusion pressure, working distance and printing speed, a greater degree 
of control and understanding of the effects of the different setup parameters is required 
and is the subject of a large volume of current research to full optimise and regulate 
machine operating parameters. Once fully understood and controlled, the layer spacing 
can be selected at the design stage and accurately produced when fabricating. 
Accuracy and reproducibility as a prerequisite for clinical translation are further 
discussed in section 5.4.4.  
5.2.2 Patient-Specific Design 
The primary focus of this research was to develop a design protocol for patient-
specific scaffolds designed from medical scan data, and to implement the method using 
clinical case studies to validate its success. This was achieved for the two case studies 
using CT data obtained from the RBH Orthopaedic Unit, as well as using photo SFM 
for educational purposes. From the measurements in Table 4, it is apparent that the 
design protocols were successful in generating anatomically accurate scaffold designs 
suitable for each defect area.  
The exterior geometry of the scaffolds was designed based on the medical-scan 
derived 3D model with sufficient resolution for the melt-electrospinning fabrication 
requirements. The use of sketch planes to define the edges of each end of the defect 
site posed some room for human error, where it was not always possible to easily 
identify and select the exact edge of the 3D model using a spline tool. Therefore, the 
external boundary of the scaffold could have been slightly imperfect in regions. It was 
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noted, however, that these inconsistencies were very slight and due to the number of 
spline points selected, the effect was deemed negligible. Ideally, however, if a 
contralateral 3D model was available, a simple subtraction could have been performed 
by mirroring the complete model on top of the defective model and identifying the 
defective region which did not appear in both models. This technique was available 
for use in the second case study and was also more time efficient.  
Ultimately, it would be ideal if the entire design stage from medical scan data 
through to implant printing could be automated. However, there are a number of 
considerations and limitations which have been identified and discussed in section 
5.3.4. While the 3D modelling programs were sufficient for this project, more suitable 
options could also be used to which have been specifically developed for anatomical 
applications. Amira (FEI, Hillsboro OR, USA) is a program for visualizing and 
manipulating models from medical data while Mimics Innovation Suite (Materialise, 
Leven, Belgium) is a biomedical engineering platform which specialises in not only 
medical image processing but also Finite Element Analysis (FEA), Computational 
Fluid Dynamics (CFD) modelling and additive manufacturing compatibility. Mimics 
incorporates not only the ability to design models in STL format, through the use of 
tessellated triangles to describe only the surface geometry of objects, but also 
functionality with more widely used formats such as Initial Graphics Exchange 
Specification (IGES, .igs files) which offers wireframe, surface and solid export files 
compatible with many other CAD programs. This allowed for easy translation of not 
only patient-specific models based on medical scan data but also the use of solid body 
models for the design of fixation devices, brackets and other additional parts which 
may need to be included in the implant design. Also featuring FDA approval, these 
programs may be suitable alternatives to the software used in this design method.  
The photo SFM data collection method was not only a useful educational tool 
for demonstrating the exciting future of biofabrication to high school students, it also 
provided an interesting insight into the potential development of the use of basic and 
easily accessible imaging options to assist patients in rural, remote or third-world 
countries with limited access to advanced medical imaging machines. If an individual 
was involved in a vehicle accident hours away from the nearest hospital, a witness 
could, in conjunction with first aid, take images of the person’s injuries and send them 
to the hospital. While the patient is in transport, a 3D printed implant could already be 
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printing for immediate implantation when the patient arrives, offering a potentially 
life-altering treatment option. It was apparent, through the post-modelling 
modification to the design based on still images and measurement of the defect area, 
that photo SFM modelling using an iPhone did not accurately capture data to the extent 
which was needed for precise customised implants. Further development and more 
advanced software could improve the quality of the resultant 3D model and allow for 
the more accurate generation of scaffold designs.  
5.2.3 Density/Porosity 
The second aim of this research was to design scaffolds with multiple regions of 
fibre spacing to facilitate the growth of different bone densities. This aim relies on 
fundamental biomimicry theory that natural cortical and trabecular bone ECM varies 
significantly in density. Therefore, to mimic each of these bone types, tissue 
engineered bone must accommodate multiple fibre spacing within the construct. With 
the technical challenge of designing melt-electrospun scaffolds with a single 
continuous fibre, the computational challenge of automatically generating g-code with 
regions of multiple fibre spacing was a significant hurdle within this project. The two 
layer configurations developed to overcome this were as follows: 
 A – Separate sections of same layer: printing less dense then more dense 
regions in same layer 
 B – Overlaying layers: overlaying a layer with inversely spaced fibres 
For Configuration A, by printing the less dense regions, followed by more dense 
regions of each layer next to each other, the g-code generator would view each region 
as separate layers, thereby instructing the pointer to change directions at the boundaries 
between these regions as well as at the edges of the scaffolds. These boundaries 
therefore resulted in a build-up of fibres along the boundary line where the pointer 
would turn around to continue fabricating each region independently, creating a dense 
polymer wall between the regions. While this would severely restrict diffusion 
between these sections of the scaffold, the segregated areas could be potentially useful 
for the inclusion of targeted signalling molecules to assist the growth of certain tissue 
types. By including cortical bone-specific bioactive ingredients in one region and 
trabecular bone-specific ingredients in another, the tissues could develop without 
cross-contamination until such time as the thick polymer wall is dissolved and the 
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tissues can begin to integrate. In contrast, it could be also considered a point of 
weakness in the scaffold where the lack of diffusion could adversely affect nutrient 
flow and starve the cells on one side of the boundary. 
For Configuration B scaffolds, the full scaffolds layers were firstly printed with 
sparse spacing and then the dense region was printed over the top. Considering the 
vastly different starting points within the image, the g-code generator would be 
unlikely to align many of the fibres. Therefore, the dense fibres would sit in between 
the sparse fibres, creating a dense network region. These two regions would remain 
relatively interconnected, since fibres aligned along the boundary would only be 
deposited on alternative layers when the dense layer is created. This theoretically 
would allow for improved interconnectivity and porosity between the two layers and 
could improve nutrient supply and movement. However, the fibres which are created 
when turning around at the boundaries of the image would likely overlap when printing 
the dense layer on top of the sparse layer, therefore depositing two fibres on top of 
each other form just one image layer. This would, over time, create a significant 
misalignment in the scaffold height between the dense regions, where twice the 
number of cross-fibres is deposited from turning around than just the single layer of 
sparse fibres. For a thick, multilayer scaffold, this could result in a large source of error 
in the scaffold design. 
These boundary considerations are certainly a point of interest for future 
characterisation studies to assess the best layer configuration for creating dual-density 
regions. 
5.2.4 Laydown Pattern 
At the edges of the scaffolds, rounded edges were observed instead of well-
defined corners as guided by the g-code. It is apparent that these rounded corners have 
also led to decreased stability at the edges of the scaffolds and random misplaced fibres 
are commonly observed. It is likely that these form as a result of the fast-moving 
collector plate and high translational speed, not leaving enough time for the polymer 
to be deposited in clean, square edges but rather ‘whipped’ around the corner. Where 
the collector plate travelled a long distance and then turned around rapidly, this often 
led to the dimensions of the scaffold being exceeded where the whipping would extend 
the scaffold beyond where it was designed. This was evident in the skull and femur 
scaffolds where the boundaries of the fabricated scaffold were measured to be slightly 
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larger than required. However, for the very small patella scaffold or thin cortical 
regions, the collector plate did not have time to reach full speed before turning around 
and therefore the polymer was pulled in at the corners, making the margins smaller 
than required. These inconsistencies are a large source of error in the laydown pattern 
and, although only slight, could compromise the success of the patient-specific 
architecture and need to be addressed. 
Additionally, a number of ‘wavy’ lines, making a sinusoidal pattern, were 
observed throughout the scaffolds. These were due to manual stage movements after 
the completion of the g-code. The collector plate was manually directed out from under 
the flow of polymer after the scaffold was completed so the power could be turned off 
and scaffold extracted. However, the manual plate movements are at a much slower 
speed than the speed required for printing and therefore the polymer is flowing much 
faster than the collector plate is moving. A wavy pattern then forms across the scaffold. 
This is entirely a printing artefact and could be removed by programming an extra line 
of code to direct the collector plate away from the newly printed scaffold before the 
polymer flow can be can be turned off. 
While the g-code generator successfully identified multiple regions within the 
complex shapes (see Figure 8), it automatically joins these together with a straight line, 
making random diagonal lines throughout the scaffold which would interfere with the 
original design of the scaffold as it printed. This did have an impact on the flat, ordered 
scaffolds such as the SD skull scaffold, where the order of the scaffold was effected 
due to the presence of a diagonal line across the scaffold. However, for the small and 
very tall patella scaffolds, these cross-lines significantly interfered with the laydown 
pattern to the extent that the external boundaries of the scaffold were completely 
altered. A presumed build-up of charge in these diagonal polymer walls would attract 
the polymer away from the desired pattern and further contribute to the build-up of 
these artefacts and detract from the accuracy of the general scaffold design. 
Particularly within the deep margin of the patella scaffold, where many diagonal lines 
per layer were deposited from the code moving between the proximal and distal ends 
of the scaffold, these lines would develop into large polymer walls which, when 
intersecting with the centre of the scaffold, led to rapidly decreased stability and 
disorder during the fabrication process. Where the wall would build up to nearly 
double the height of the actual scaffold, the printing process had to be terminated. 
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5.3 FUTURE WORK 
5.3.1 Layer Alignment 
A significant drawback to the g-code generation program used in this research 
was the non-alignment of fibres between layers. It was particularly evident in the g-
code visualisation and micrographs that since the g-code for each layer was 
independently generated, while subsequent layers might have the same fibre spacing, 
the fibres didn’t align due to the varying starting points on the images. The biological 
ramifications of this include the possible restriction of nutrient flow within the 
scaffold; this is one of the primary drawbacks of non-ordered micron-scale scaffolds 
as discussed in sections 2.1.2 and 2.2.3. By restricting diffusion and in the z-direction, 
where diffusion is already restricted in x and y due to the fabrication crosshatch pattern, 
the scaffold cannot sustain biological function without interconnected pores and the 
structure would ultimately succumb to cell necrosis.  
Moving forward, to rectify this non-alignment issue, a number of approaches 
could be added into the g-code generation program code to ensure fibre alignment 
between layers. 
1. Snap to Grid: Fibres ‘snap’ to a grid of evenly spaced lines so that on each 
layer, the fibres will directly align with those below. 
2. Fixed starting point, integer spacing: By fixing a common starting point 
between the images, each successive image will begin being filled at the 
same point. With integer spacing across the image, this will ensure that even 
with different geometries, successive layers will be predominantly aligned. 
However, even with aligned fibres, it was evident in the dual-density skull 
scaffold, where the density varied in the transverse plane, that printing layers with 
double the density (half the fibre spacing) results in fibres ‘sagging’ between struts of 
the region below it and a high level of disorder was observed. Measures to overcome 
this and ensure ordered scaffold layers where they do not directly match the one below 
will require further investigation, including the optimisation of parameters such as 
extrusion temperature which could assist the fibres in setting more rapidly before 
bending onto the layers below. 
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5.3.2 Tailored Tissue Growth 
While this study validates the feasibility of designing more complex scaffolds 
with variable internal architecture, further research is required to validate its use 
biologically. Two methods of preparing dual-density scaffolds offer substantially 
different physical design characteristics, particularly at the boundary between different 
density regions. While the fibre spacing for ‘cortical’ and ‘trabecular’ bone tissue 
growth were selected as 500µm and 1000µm spacing respectively for the purposes of 
this study, in vitro trials and characterisation would be required to determine the 
optimal fibre spacing required for optimising each of these tissues. Furthermore, using 
MRI diffusion characterisation, as established by Powell et al. (2014), as well micro-
CT analysis and in vitro studies, the growth of cells within these structures can be 
optimised to enhance tissue regeneration multi-zonal scaffolds for the different density 
bones: cortical and trabecular. 
5.3.3 Stability 
Successfully fabricating the scaffold designs to a level of absolutely precision 
was beyond the scope of this thesis. However, ultimately, melt-electrospinning 
machines must overcome the widely recognised stability issues to be able to fabricate 
scaffolds of a variety of shapes and sizes to treat bone loss. With a current height limit 
of approximately 2mm, the fabricated scaffolds were all significantly shorter than the 
required design, as shown in Table 4. It is therefore apparent that further research into 
the mechanical setup of the machine is required to stabilise and optimise the deposition 
of polymer at heights greater than this. Already, research in the mechanical 
engineering discipline has identified more advanced high voltage power 
configurations which create a more stable environment for the fabrication of scaffolds 
(Ristovski et al., 2015) and further research including the use of other collector plate 
configurations and materials (Hochleitner et al., 2015). 
5.3.4 Automaticity 
For clinical implementation, the biofabrication process must be automated, 
simple and reliable, sterile, requiring minimal human/machine interfacing or 
additional training to ease the transition into clinical use. Currently, to create patient-
specific scaffolds, one requires imaging specialists to collect medical scans, computer 
modelling experts to design 3D computer models of the defect site, biologists and 
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medical engineers to dictate the required design of the scaffold and finally 
software/coding specialists to then translate the design into something which can be 
3D printed before it can be given to an orthopaedic surgeon to surgically implant. The 
combination of such expertise would not be readily available in the common 
orthopaedic surgery clinic and as such, an automated three-stage design process is 
recommended: 
 External Architecture: The machine must be able to take the medical scans 
to identify and directly model the various tissue types with the defect areas and 
translate the anatomical and physiological requirements into a suitable implant 
design. This would require advanced 3D modelling software which can 
automatically segment and render the design based on clinically available CT, 
MRI or X-ray data. The external architecture of the scaffold must be consistent 
with the surrounding tissue and consider structural and functional requirements 
according to the location. While ideally this would be an entirely automated 
process, as discussed in section 5.2.2, it would certainly require input by the 
surgeon to plan the surgical procedure. Expert intervention in the design and 
treatment planning stage is required, since the role of the orthopaedic surgeon, 
including identification of the injury, anomalies, intuition and experience can 
not yet be accumulated into a computer program  
 Internal Architecture: As discussed earlier, studies have revealed the huge 
importance of combining porosity and vascularisation to ensure tissue 
functionality. Micro-architectural constructs must be automatically inserted 
into the design depending on the tissue type, structure and mechanical loading, 
all of which is based on ongoing pre-clinical trials which are already 
investigating the effects of porosity and architecture on how well a tissue can 
regenerate.  
 Machine Parameters: The automated system would need to translate the 
scaffold design into a series of commands to be executed by the additive 
manufacturing machine, accounting for regions requiring support structures 
and additional reinforcement during the fabrication process. Already, some 3D 
printers use a dissolvable printing material to create the support structures 
which can be washed away during immersion in soapy water post-fabrication. 
However this approach is not viable for scaffold with biological materials 
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already suspended within them such as hydrogels and growth factors as these 
would not survive the post-fabrication treatments. 
5.4 LIMITATIONS AND CHALLENGES 
Although 3D printed scaffolds offer a revolution in the orthopaedic treatment of 
bone defects, as well as many other conditions, there exist a multitude of challenges 
that must be overcome before our medical services are able to adopt this technology.  
5.4.1 Versatility 
A robust biofabrication solution would be able to produce multiple tissue types 
using different biomaterials, structures, designs and bioactive ingredients. As 
discussed in the literature case studies (section 2.3.3), there are also possibilities for 
incorporating other tissues within scaffolds to treat complex disorders such as 
osteoarthritis by regenerating both bone and cartilage. 
The user should be able to select several key parameters, perhaps as buttons on 
the device itself, before the machine automatically combines the requirements in a 
design and fabricates the implant. Examples are summarised in the table below. 
Table 6 Automated biofabrication machine selection parameters.  
Category Selection Options 
Tissue type e.g. Bone, Cartilage, Muscle  
Biomaterial degradation rate Types of polymers most suitable to the defect area 
Bioactive ingredients  e.g. Growth Factors, Anticoagulants, Drugs, Hormones  
Cells e.g. Autologous stem cells  
 
In combination with the automated design (section 5.3.4) as well as calculation 
of required volumes for biomaterials and dosages of bioactive ingredients based on the 
volume, the complete system would allow for systematic input of the optimised 
requirements, as selected by the surgical team, followed by rapid fabrication. This 
significant challenge is also accompanied by a number of other hurdles which must be 
overcome, namely, the ability for the printer to accurately fabricate constructs in a 
clinically-feasible time frame and sterile environment. These will be discussed below. 
5.4.2 Speed 
Current additive manufacturing techniques are yet to offer the required 
fabrication speed necessary to produce patient-specific scaffolds within a clinically-
feasible timeframe. Ideally, scaffolds should be able to be produced within 4 hours for 
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immediate surgical implantation, including the time required to successfully add 
biological ingredients. Assessing the feasibility of implementing 3D medical printers 
in hospitals will include determining if superfluous surgical wait times are incurred 
due to lengthy fabrication times. This could potentially increase surgical costs and 
therefore diminish the commercial and clinical viability of the technology. 
5.4.3 Sterility 
Maintaining a completely sterile fabrication environment is another challenge 
yet to be overcome. FDA approval will require stringent sterility control before 
approving any biofabrication product for clinical use. Biofabrication machines will 
require highly controlled temperature, humidity and gas exchange for the maintenance 
of a sterile fabrication environment. Detachable components suitable for autoclave as 
well as disposable components will most likely be utilised to facilitate straightforward 
cleaning and sterilisation procedures. While these requirements are easily overcome, 
they present another consideration for the design and development of new fabrication 
technologies 
5.4.4 Accuracy 
Before clinical use, additive manufacturing techniques will need to demonstrate 
accuracy and reproducibility in fabricating scaffolds for implantation. Regulatory 
agencies in many countries oversee the implementation of Good Manufacturing 
Practice (GMP) conditions, which ensure that products meet the minimum quality 
requirements. For techniques such as melt-electrospinning which have been shown to 
have a high degree of printing instability and variance in reproducibility, as discussed 
in section 5.3.3, further development of the equipment will be required to meet these 
standards. 
5.4.5 Ethical and Social Challenges 
The FDA makes headlines with each successive revolutionary approval, most 
recently approving the first ‘3D Printed Drugs’ (Aprecia Pharmaceuticals, 2015) as 
well as the 3D printed OsteoFab® Patient-Specific Facial Device (OPSFD) (Oxford 
Performance Materials, Inc, South Windsor CT, USA) for facial reconstructions 
(Nasdaq GlobeNewswire, 2014). In 2015 alone, the FDA cleared over 3000 medical 
device products through their Premarket Notification Process [501(k)] (U.S. Food and 
Drug Administration, 2016). However, only 85 products using 3D printing have been 
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given clearance in the history of the FDA (Hartford, 2015). Largely, technical concerns 
have been centred around issues of sterility and biocompatibility without unwanted 
side effects.  
Commercialisation may be limited by the legislative classification of 
biofabrication devices which, currently, would fall between the definition of medical 
devices and drugs due to the inclusion of biological materials such as growth factors. 
Progression of legislation, at a national and international level, to match significant 
biofabrication innovations will be required to ensure rapid translation of these devices 
into the clinical use without delay. In a special section of the Tissue Engineering 
journal, titled Regulation Policy on Tissue Engineering and Regenerative Medicine in 
Asian—Pacific Countries, Liu et al. (2015) recently recognised that “given that there 
are now many available and sophisticated Tissue Engineering and Regenerative 
Medicine (TERM) techniques that have shown evidence of efficacy, that there are a 
large number of patients fit for TERM therapy, and that there is a large potential market 
for TERM products, it is increasingly clear that the policies and procedures of TERM 
regulation are one of the key issues that is stalling the translation process.” (W. Liu, 
Burdick, & van Osch, 2015) Also, while Normal America and European countries are 
regulated by the FDA and European Medicines Agency (EMA) respectively, Asia-
Pacific countries are more often bound only by the ethical committees of their 
respective institutes and national policies and use small-scale clinical trials for the 
basis of their clinical therapies (W. Liu et al., 2015). 
While the impact of 3D printing in medicine is only beginning to be recognised, 
the ethical considerations of bringing this technology into the routine clinical sphere 
have already been the subject of widespread debate. At the forefront is the inevitable 
reality that this technology could be used to not only restore and repair patients 
suffering from injuries but also to improve and enhance the body to what could be 
considered beyond ‘normal’ human capacity. The topic of human enhancement was 
recently discussed by Prof Susan Dods, posing the question “should we consider 
replacing our existing bones with artificial ones that are stronger and more flexible, 
less likely to break; or improving muscle tissue so that it is more resilient and less 
likely to become fatigued, or implanting new lungs that oxygenate blood more 
efficiently, even in a more polluted environment?” (Dodds, 2015) Drawing distinct 
parallels to the ethical debate of elite athlete performance enhancement using new 
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technologies driven predominantly by pharmaceutics, this controversial ethical 
consideration will be the subject of much public and academic debate while the 
prospects of using 3D printed body parts draws nearer to clinical reality. 
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Chapter 6: Conclusions 
In this thesis, a novel method for designing 3D printed scaffolds based on 
clinically relevant data was developed. The method involved translating patient data 
from CT scans or photo SFM into a 3D model and using that to guide the internal and 
external structure of the scaffolds. Regions of varying porosity were also considered 
so the scaffolds could more closely mimic the native tissue. Each scaffold was 
individually customised to fit the defect geometry while also incorporating several key 
bone regeneration requirements: biocompatibility, biodegradability and controlled 
porosity. Three case studies were undertaken and scaffolds were fabricated to assess 
the success of the generated computer instructions which guided the fabrication 
process. Within the context of a wide body of research at QUT developing melt-
electrospun scaffolds for bone regeneration, this project facilitates the ability for the 
team to now design anatomically customised scaffolds using a highly specialised 3D 
printing technique. 
Biofabrication is revolutionising orthopaedic treatments and approaches to 
restoring lost tissue, and this research project . In the future, 3D printers will be 
installed in hospitals around the world and will be able to custom-fabricate structures 
to fully restore tissue function, providing a cheap, on-demand, sterile, low-risk 
alternative to grafting. Ultimately, this technology will improve surgical successes, 
patient outcomes and the overall quality of life of millions of patients around the world. 
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Appendix B 
Mathematica G-code Viewer 
a=Import["U:/IHBI/ResearchGroups/BiomaterialsTissueMorpho
logy/BTM Folder Structure/Nathan 
Crooks/Misc/Electrospinning Control 
Programs/Auto_Pattern_Generator - 
Incomplete/Coordinates.txt","CSV"]; 
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